publication_id,tool,quote,best_match_source,best_match,similarity
1528,PRECIS-2,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",fulltext,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",100.0
1528,PRECIS-2,"Of the 311 patients identified, 221 (71%) met the criteria for having low mood. Of these, 72 were randomly allocated to receive treatment and 79 to usual care.",fulltext,"Of the 311 patients identified, 221 (71%) met the criteria for having low mood. Of these, 72 were randomly allocated to receive treatment and 79 to usual care.",100.0
1528,PRECIS-2,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post. This booklet included the measures administered at baseline, the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and in addition the BDI-II,6 a measure of the severity of depression.",fulltext,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post. This booklet included the measures administered at baseline, the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and in addition the BDI-II, 6 a measure of the severity of depression.",100.0
1528,PRECIS-2,If participants failed to return outcome questionnaires they were telephoned once to remind them.,fulltext,If participants failed to return outcome questionnaires they were telephoned once to remind them.,100.0
1528,PRECIS-2,"Participants randomly allocated to the adjustment group received six group treatment sessions. The control group received usual care, which did not include psychological interventions.",fulltext,"Participants randomly allocated to the adjustment group received six group treatment sessions. The control group received usual care, which did not include psychological interventions.",100.0
1528,PRECIS-2,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",fulltext,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",100.0
1528,PRECIS-2,"The intervention was targeted at mood, and the EQ-5D assesses other aspects of quality of life that would not be affected by the intervention.",fulltext,"the intervention was targeted at mood, and the EQ-5D assesses other aspects of quality of life that would not be affected by the intervention.",100.0
1528,PRECIS-2,"People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",fulltext,"People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",100.0
1528,PRECIS-2,"The EQ-5D5 was included as a generic quality of life measure. To ascertain costs, a questionnaire was used to assess the use of NHS services and prescribed medication in the previous three months.",fulltext,"The EQ-5D 9 was included as a generic quality of life measure. To ascertain costs, a questionnaire was used to assess the use of NHS services and prescribed medication in the previous three months.",99.48979591836735
1528,PRECIS-2,"The details of this study have been published elsewhere.3 However, in summary, participants were included who scored >2 on the General Health Questionnaire 12,7 a measure of psychological distress, or >7 on the anxiety and depression subscales",fulltext,"The details of this study have been published elsewhere. 3 However, in summary, participants were included who scored >2 on the General Health Questionnaire 12, 7 a measure of psychological distress, or >7 on the anxiety and depression subscales",100.0
1529,PRECIS-2,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",fulltext,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",100.0
1529,PRECIS-2,"Depression, anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard Scale before and immediately and three months after the implementation of FHM.",fulltext,"Depression, anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard Scale before and immediately and three months after the implementation of FHM.",100.0
1529,PRECIS-2,"The intervention was implemented within two days a week. For the control group, a routine protocol was conducted. For blinding, the patients of the control group referred to the Society on certain days of week and those of the experimental on other days.",fulltext,"The intervention was implemented within two days a week. For the control group, a routine protocol was conducted. For blinding, the patients of the control group referred to the Society on certain days of week and those of the experimental on other days.",100.0
1529,PRECIS-2,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization–the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the fourth session); the technique of increasing social relationships, the technique of expressing emotions, the technique of being intimate (the fifth session).",fulltext,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization–the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the F. Khayeri et al. / Complementary Therapies in Clinical Practice 25 (2016) 130e135 131 fourth session; the technique of increasing social relationships, the technique of being the real self (the fifth session). The technique of increasing intimacy as the ",96.27659574468085
1529,PRECIS-2,"Depression, anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard Scale",fulltext,"Depression, anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard Scale",100.0
1529,PRECIS-2,"According to this study, the FHM was effective in relieving depression, stress, fatigue, and to some extent, anxiety. Because of being implemented easily, being safe and accessible, causing no risk to the patient and his/her family as well as no costs, which is currently one of the concerns of health care system, FHM is recommended to be conducted on patients with psychiatric disorders especially MS.",fulltext,"According to this study, the FHM was effective in relieving depression, stress, fatigue, and to some extent, anxiety. Because of being implemented easily, being safe and accessible, causing no risk to the patient and his/her family as well as no costs, which is currently one of the concerns of health care system, FHM is recommended to be conducted on patients with psychiatric disorders especially MS.",100.0
1529,PRECIS-2,"In this clinical trial, 140 MS patients assigned to experimental and control groups. Depression, anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard Scale before and immediately and three months after the implementation of FHM.",fulltext,"In this clinical trial, 140 MS patients assigned to experimental and control groups. Depression, anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard Scale before and immediately and three months after the implementation of FHM.",100.0
1529,PRECIS-2,This clinical trial was conducted in 2015–2016 and registered as IRCT2014112420064N1 in the Iranian Register of Clinical Trials. The study population consists the patients referring to the Multiple Sclerosis Society of Isfahan.,fulltext,This clinical trial was conducted in 2015e2016 and registered as IRCT2014112420064N1 in the Iranian Register of Clinical Trials. The study population consists the patients referring to the Multiple Sclerosis Society of Isfahan.,99.55947136563876
1567,PRECIS-2,"Data analyses were conducted using SPSS, version 24.0 for Windows (SPSS Inc., Chicago, IL, USA). Neuropsychological data were scored by the testers and verified by a second staff member. Data were entered and checked for accuracy. Internal consistency reliability coefficients for all self-report measures were .80 or above. Descriptive analyses were performed to obtain a profile of the sample. The groups were compared at baseline on demographic and disease variables. Preliminary analysis for assumptions of normality, independence of errors, homogeneity of variance, and outliers suggested that assumptions had generally been met and therefore data transformations were deemed unnecessary.",fulltext,"Data analyses were conducted using SPSS, version 24.0 for Windows (SPSS Inc., Chicago, IL, USA). Neuropsychological data were scored by the testers and verified by a second staff member. Data were entered and checked for accuracy. Internal consistency reliability coefficients for all self-report measures were .80 or above. Descriptive analyses were performed to obtain a profile of the sample. The groups were compared at baseline on demographic and disease variables. Preliminary analysis for tests of assumptions such as normality, independence of errors, homogeneity of Table 1 Selected examples of cognitive tasks/games in Lumosity program. Game Cognitive Domain Construct Birdwatching Attention Visual field WordBubbles Flexibility/Executive Functioning Verbal fluency MonsterGarden Memory Working memory BytheRules Problem Solving Logical reasoning PenguinPursuit Processing Speed Spatial orientation A.K. Stuifbergen et al. / Disability and Health Journal 11 (2018) 427e434 429 variance, and outliers suggested that assumptions had generally been met and therefore data transformations were deemed unnecessary.",99.71139971139971
1567,PRECIS-2,"Using effect size estimates from prior research7 a total sample size of 180 was determined to be sufficient to detect an effect size (f) of .28 as statistically significant (assuming an alpha level of .05).8 Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites. The project staff used a script to screen potential participants and explain the study requirements to those who called the toll-free number and met eligibility criteria (18–60 years of age, able to understand and comply with the study protocol, visual acuity sufficient to read on-screen text on a computer screen, clinically definite MS for at least 6 months and exacerbation free for 90 days). The Perceived Deficits Questionnaire9 was administered by phone, and those scoring at least 10 (indicating some problems in at least 5 areas) were eligible to participate.",fulltext,"Using effect size estimates from prior research 2 a total sample size of 180 was determined to be sufficient to detect an effect size (f) of .28 as statistically significant (assuming an alpha level of .05). 18 Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites. The project staff used a script to screen potential participants and explain the study requirements to those who called the toll-free number and met eligibility criteria (18e60 years of age, able to understand and comply with the study protocol, visual acuity with correction sufficient to work on a computer screen, clinically definite MS for at least 6 months and exacerbation free for 90 days). The Perceived Deficits Questionnaire 19 was administered by phone, and those scoring at least 10 (indicating some problems in at least 5 areas) were eligible to participate.",98.40604026845638
1567,PRECIS-2,"The computer component enabled participants (N = 63) to engage in practice of cognitive strategies without the direct supervision of project staff, the study was designed to determine the effectiveness of a novel computer-assisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",fulltext," cognitive changes commonly experienced by persons with MS. Objective: The primary purpose of this study was to determine the effectiveness of a novel computerassisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",70.35040431266846
1567,PRECIS-2,"Although positive change in verbal memory, compensatory strategies and lifestyle activities that support cognitive functioning (e.g., sleep and rest, exercise) paired with a home-based computer-assisted cognitive training program. The computer component enabled participants (N = 63) to engage in practice of cognitive strategies without the direct supervision of project staff, the study was designed to determine the effectiveness of a novel computer-assisted cognitive rehabilitation intervention MAPSS-MS",fulltext," compensatory strategies and lifestyle activities that support cognitive functioning (e.g., sleep and rest, exercise) paired with a home-based computer-assisted cognitive training program. The computer component enabled participants (N ¼ 63) to engage in practice sessions without leaving their homes. Overall, the study supported the feasibility of the MAPSS-MS intervention (compliance with the intervention wa",68.89763779527559
1567,PRECIS-2,"The MAPSS-MS intervention aims to help persons with MS acquire the highest level of cognitive functioning and functional independence. The intervention includes group sessions (2 h per week for 8 weeks) focused on building efficacy for use of cognitive strategies and a home-based computer training program (45 min three times per week). Based on the integration of abilities, the train efficacy theory20 with the investigators' prior intervention studies,21,22 the program's conceptual model proposes testing knowledge of cognitive problems, lifestyle adjustments (sleep, stress management, physical activity) that support cognitive functioning, and self-efficacy to manage cognitive challenges that support persons with MS in the use of compensatory cognitive strategies and cognitive skills.",fulltext,"The MAPSS-MS intervention aims to help persons with MS acquire the highest level of cognitive functioning and functional independence. The intervention includes group sessions (2 h per week for 8 weeks) focused on building efficacy for use of cognitive strategies and a home-based computer training program (45 min three times per week). Based on the integration of Bandura's selfefficacy theory 20 with the investigators' prior intervention studies, 21,22 the program's conceptual model proposes accurate knowledge of cognitive problems, lifestyle adjustments (sleep, stress management, physical activity) that support cognitive functioning, and self-efficacy to manage cognitive challenges will support persons with MS in the use of compensatory cognitive strategies and cognitive skills.",96.72544080604534
1567,PRECIS-2,"Participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",fulltext,"Participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",100.0
1567,PRECIS-2,delivered to 10 cohorts of 8–12 persons at three sites over a 34-month period.,fulltext,delivered to 10 cohorts of participants across the three sites over a 34-month period.,89.74358974358975
1568,PRECIS-2,Included in intention-to-treat analysis (n=42),prompt,included in the analysis o,52.17391304347826
1568,PRECIS-2,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,fulltext,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,100.0
1568,PRECIS-2,Follow-up (24 weeks),prompt,Follow-up: How,60.0
1568,PRECIS-2,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopulos and Felson Duchan)13: (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",fulltext,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan) 13 : (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",100.0
1568,PRECIS-2,"The exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients' individual maximal heart rate (HRmax), and progressed within and between 4 meso cycles of 12 weeks. In brief, the exercise intervention included 3892 minutes of aerobic exercise at an average intensity of 76.2% HRmax.",fulltext,"the exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients’ individual maximal heart rate (HRmax), and progressed within and between 4 meso cycles of 12 weeks. In brief, the exercise intervention included 3892 minutes of aerobic exercise at an average intensity of 76.2% HRma",99.38461538461539
1568,PRECIS-2,"The purpose of providing health educational sessions was primarily to facilitate adherence in the control group, as a previous study showed no effect of health education on MS-related symptoms and a null effect on the outcomes of the present study was therefore expected.14 Otherwise the patients were left to self-administered behaviour.",fulltext,"The purpose of providing health educational sessions were primarily to facilitate adherence in the control group, as a previous study showed no effect of health education on MS-related symptoms and a null effect on the outcomes of the present study was therefore expected. 14 Otherwise the patients were left to selfadministered behaviour.",99.11242603550295
1568,PRECIS-2,Patients (n=84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,fulltext,Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,100.0
1568,PRECIS-2,Follow-up (48 weeks),prompt,Follow-up: How,60.0
1568,PRECIS-2,"Patients (n=84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60 years of age, (2) ⩾2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",fulltext,"Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",100.0
1569,PRECIS-2,"Five patients in the TOCT group did not complete the 12-weeks home-based TOCT (1 due to MS worsening, 3 for personal issues, 1 discontinued the intervention).",fulltext,"Five patients in the TOCT group did not complete the 12-weeks home-based TOCT (1 due to MS worsening, 3 for personal issues, 1 discontinued the intervention).",100.0
1569,PRECIS-2,"A full description of exercise protocol is available elsewhere (Straudi et al., 2014). They were encouraged to increase their level of function among sessions. They underwent two laps during each session that take about 60 min (6 workstations x 5 min x 2 laps), with 10 min of rest after each lap. In addition, the walking practice was trained by 30 min walking on the treadmill, including rests if necessary.",fulltext," A full description of exercise protocol is available elsewhere (Straudi et al., 2014). They were encouraged to increase their level of functioning among sessions. They underwent two laps during each session that take about 60 min (6 workstations x 5 min x 2 laps), with 10 min of rest after each lap. In addition, the walking practice was trained by 30 min walking on the treadmill, including rests if necessary",99.75550122249389
1569,PRECIS-2,Modified Intention-To-Treat analysis (n= 18) Lost to 12-weeks assessment (n= 5): MS worsening (n=1) Personal issues (n=3) Discontinued home-based intervention (n= 1),fulltext,"e 12-weeks home-based TOCT (1 due to MS worsening, 3 for personal issues, 1 discontinued the intervention)",50.303030303030305
1569,PRECIS-2,The Multiple Sclerosis Task-Oriented Circuit Training (MS TOCT) trial is an assessor-blinded randomized controlled trial approved by the Ferrara Ethics Committee (registration number 140489) and registered on the ClinicalTrials.gov database (NCT02421744). Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,fulltext, The Multiple Sclerosis Task-Oriented Circuit Training (MS_TOCT) trial is an assessor-blinded randomized controlled trial approved by the Ferrara Ethics Committee (registration number 140489) and registered on the ClinicalTrials.gov database (NCT02421744). Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation,99.50248756218906
1569,PRECIS-2,"The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance (Goldman et al., 2008). As secondary outcomes, we selected: i) Timed 25-Foot Walk (T25FW) (Gijbels et al., 2012) for gait speed; ii) Timed Up and Go Test (TUG) for mobility (Podsiadlo and Richardson, 1991); iii) Dynamic Gait Index (DGI) for balance (Forsberg et al., 2013); iv) Modified Fatigue Impact Scale (MFIS) (Téllez et al., 2005) for physical (MFIS-phy), cognitive (MFIS-c) and psychosocial fatigue (MFIS-psy); Multiple Sclerosis Walking Scale–12 (MSWS-12) (Hobart et al., 2003) for perceived walking ability.",fulltext," The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance (Goldman et al., 2008). As secondary outcomes, we selected: i) Timed 25-Foot Walk (T25FW) (Gijbels et al., 2012) for gait speed; ii) Timed Up and Go Test (TUG) for mobility (Podsiadlo and Richardson, 1991); iii) Dynamic Gait Index (DGI) for balance (Forsberg et al., 2013); iv) Modified Fatigue Impact Scale S. Straudi et al. Multiple Sclerosis and Related Disorders 60 (2022) 103721 3 (MFIS) (T ´ ellez et al., 2005) for physical (MFIS-phy), cognitive (MFIS-c) and psychosocial fatigue (MFIS-psy); Multiple Sclerosis Walking Scale–12 (MSWS-12) (Hobart et al., 2003) for perceived walking ability",99.66832504145937
1569,PRECIS-2,"The experimental group performed functional tests, questionnaires and instrumental measurements at baseline, after Phase 1 and after Phase 2. Retention was tested on the whole sample at a 12-weeks follow-up.",fulltext,"tcome measures at baseline, after Phase 1 and after Phase 2. Retention was tested on the whole sample at a 12-weeks follow-up.",60.86956521739131
1569,PRECIS-2,"Thirty-six PwMS were enrolled in the study (mean age 50.82, 13 males, 11.6 MS years). One patient in the TOCT group and one in the delayed-TOCT group did not receive the allocated treatment due to a post-randomization drop-out.",fulltext,"Thirty-six PwMS were enrolled in the study (mean age 50.82, 13 males, 11.6 MS years). One patient in the TOCT group and one in the delayed-TOCT group did not receive the allocated treatment due to a post-randomization drop-out.",100.0
1570,PRECIS-2,"Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI",fulltext,"Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI",100.0
1570,PRECIS-2,"The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 2005-2006, who had the following criteria:",fulltext,"Methods The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 20052006, who had the following c",95.40816326530613
1570,PRECIS-2,Finally analysis was performed using SPSS v13.,fulltext,Finally analysis was performed using SPSS v13.,100.0
1570,PRECIS-2,"At the end of 24 months the patients were again evaluated for EDSS, and the number of relapses for each patient was calculated (cases of pseudoexacerbation were not considered as relapse).",fulltext,"At the end of 24 months the patients were again evaluated for EDSS, and the number of relapses for each patient was calculated (cases of pseudoexacerbation were not considered as relapse).",100.0
1570,PRECIS-2,"The obtained information were entered in a questionnaire so that the amount of increase or decrease of the patients' disability after the end of treatment in the three groups could be evaluated and compared. For comparison of the primary and final EDSS in each group the paired samples t.test, for comparison of the changes in the primary and final EDSS between the groups, the One-Way ANOVA test and for comparison of side effects between the three drugs, the Pearson- chi-square were used.",fulltext," analysis The obtained information were entered in a questionnaire so that the amount of increase or decrease of the patients` disability after the end of treatment in M. Mazdeh, et al. Acta Medica Iranica, Vol. 48, No. 2 (2010) 85 the three groups could be evaluated and compared. For comparison of the primary and final EDSS in each group the paired samples t.test, for comparison of the changes in the primary and final EDSS between the groups, the One-Way ANOVA test and for comparison of side effects between the three drugs, the Pearson- chi-square ",97.9633401221996
1570,PRECIS-2,At the onset of treatment all of the patients had an EDSS of less than 6.,fulltext,At the onset of treatment all of the patients had an EDSS of less than 6.,100.0
1570,PRECIS-2,"Exclusion criteria were as follows: 1) history of malignancy within the past five years 2) history of HIV infection, positive serology for hepatitis B and C 3) history of infectious disease within six weeks prior to the study and need for hospitalization from an infectious cause within two months prior to the study 4) any kind of hematological abnormality such as lymphocyte count ≤ 1 x 10⁹/ L , platelet count ≤ 100 x 10⁹/ L , neutrophil count ≤ 1.5 x 10⁹/ L ,and hemoglobin level ≤ 8.5 g/dl",fulltext," than 6. Exclusion criteria were as follows: 1) history of malignancy within the past five years 2) history of HIV infection, positive serology for hepatitis B and C 3) history of infectious disease within six weeks prior to the study and need for hospitalization from an infectious cause within two months prior to the study 4) any kind of hematological abnormality such as lymphocyte count ≤ 1 x 10 9 / L , platelet count ≤ 100 x 10 9 / L , neutrophil count ≤ 1.5 x 10 9 / L ,and hemoglobin level ≤",97.57085020242914
1570,PRECIS-2,Ninety patients were included in this study with an average age of 31.11± 8.62 with a minimum of 14 and maximum age of 50.72(80%) were female and 20(20%) were male.,fulltext,. Results Ninety patients were included in this study with an average age of 31.11± 8.62 with a minimum of 14 and maximum age of 50.72(80%) were female and 18(20%) ,92.6829268292683
1769,PRECIS-2,"Their evidence that long-term maintenance treatment continued for years is effective is less convincing, however.",fulltext,"Their evidence that long-term maintenance treatment continued for years is effective is less convincing, however.",100.0
1769,PRECIS-2,2 patients in the treated group and two control patients died. Corticotrophin may have contributed to the death of 1 patient.,fulltext, patients in the treated group and two control patients died. Corticotrophin may have contributed to the death of 1 patient.,99.2
1769,PRECIS-2, of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.,fulltext, of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.,100.0
1769,PRECIS-2,"Corticotrophin was reduced from 15 to 10 units daily and ampicillin was advised for the urinary infection. She was admitted to hospital on May 6, 1966, in bacteraemic shock; temperature 103°F (39-3°C), pulse-rate 120 per minute, blood-pressure 70/40 mm. Hg. Despite intravenous hydrocortisone and other therapy, intramuscular cortisone acetate, and chloromycetin she died the following day.",fulltext,"Corticotrophin was reduced from 15 to 10 units daily and ampicillin was advised for the urinary infection. She was admitted to hospital on May 6, 1966, in bacteraemic shock: temperature 103&deg;F (393&deg;C), pulse-rate 120 per minute, blood-pressure 70/40 mm. Hg. Despite intravenous hydrocortisone and noradrenaline, intramuscular cortisone acetate, and chloromycetin she died the following day.",97.43589743589743
1769,PRECIS-2,"The trial was carried out in three cities-Belfast, Leeds, and Manchester.",fulltext," was started in 1963 in three citiesBelfast, Leeds, and Manchester.",78.08219178082192
1769,PRECIS-2,181 patients with multiple sclerosis were treated with corticotrophin daily for eighteen months. There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 169 control patients observed and scored in a similar way for the same period of time.,fulltext,81 patients with multiple sclerosis were treated with corticotrophin daily for eighteen months. There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 169 control patients observed and scored in a similar way for the same period of time.,99.68051118210862
1769,PRECIS-2,"The treated group were given corticotrophin (' Acthar ' gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet. The dose of corticotrophin was adjusted to produce just enough ",fulltext,"The treated group were given corticotrophin (’ Acthar ’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet. The dose of corticotrophin was adjusted to produce just enough ",100.0
1770,PRECIS-2,"Patients were allocated in a stratified randomisation to treatment with either bed rest during 3 weeks and a synthetic ACTH depolpreparation (1 mg, 100 units, tapered over 12 weeks), and Vitamin B-complex or bed rest and Vitamin B-complex intramuscular injections in the same scheme (5). Bed rest has traditionally been prescribed in our clinic, because of a positive clinical experience, though no firm scientific ground can be presented to support this form of treatment (5).",fulltext,"Patients were allocated in a stratified randomisation to treatment with either bed rest during 3 weeks and a synthetic ACTH depotpreparation (1 mg, 100 units, tapered over 12 weeks), and Vitamin B-complex or bed rest and Vitamin B-complex intramuscular injections in the same scheme (5). Bed rest has traditionally been prescribed in our clinic, because of a positive clinical experience, though no fkm scientific ground can be presented to support this form of treatment (5)",99.16142557651992
1770,PRECIS-2,"To compare the demographic data and treatment results in both groups, the two-sided Mann-Whitney U test was used with exception of the disease stages (RR, PR, and PP) in which we used the Chi-square test.",fulltext,"To compare the demographic data and treatment results in both groups, the two-sided Mann-Whitney U test was used with exception of the disease stages (RR, PR, and PP) in which we used the Chi-square test.",100.0
1770,PRECIS-2,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",fulltext,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",100.0
1770,PRECIS-2,"Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged. This was due to a changing attitude towards bed rest and the introduction of short term high dose methylprednisolone treatment (9), which rapidly has gained a wide acceptance among neurologists.",fulltext,"Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged. This was due to a changing attitude towards bed rest and the introduction of short term high dose methylprednisolone treatment (9), which rapidly has gained a wide acceptance among neurologists.",100.0
1770,PRECIS-2,"Follow-up lasted one year. In some Kurtzke Functional Systems, the Ambulation Index and the Kurtzke Incapacity Scale a transient greater improvement in the ACTH-treated patients was observed. These superior results in the ACTH group were no longer present at 6 months. Significantly more side-effects were reported in the ACTH-group. After treatment with ACTH a higher, though not statistically significant, relapse rate in the following months was noticed.",fulltext,"Follow-up lasted one year. In some Kurtzke Functional Systems, the Ambulation Index and the Kurtzke Incapacity Scale a transient greater improvement in the ACTH-treated patients was observed. These superior results in the ACTH group were no longer present at 6 months. Significantly more side-effects were reported in the ACTHgroup. After treatment with ACTH a higher, though not statistically significant, relapse rate in the following months was noticed.",99.78118161925602
1770,PRECIS-2,"Only patients with a clinical or laboratory supported definite diagnosis of MS according to the Poser criteria, suffering from a relapse, were included.",fulltext,"ported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",69.07894736842105
1771,PRECIS-2,"All intervention outcomes were replicated, except for the delayed recall of the Spatial Recall Test, where the waitlist group improved more after the delayed exercise intervention (+ 2.5 (0.1;4.8); p = 0.04).",fulltext,"All intervention outcomes were replicated, except for the delayed recall of the Spatial Recall Test, where the waitlist group improved more after the delayed exercise intervention (+2.5 (0.1;4.8); p = 0.04).",99.51923076923077
1771,PRECIS-2,"Participants were recruited between April 2016 and October 2017. From a total of 148 patients invited to participate, 86 were enrolled (Figure 1) and randomly assigned to the PAE or waitlist group (Table 1).",fulltext,"Participants were recruited between April 2016 and October 2017. From a total of 148 patients invited to participate, 86 were enrolled (Figure 1) and randomly assigned to the PAE or waitlist group (Table 1).",100.0
1771,PRECIS-2,"After 24 weeks, the waitlist group underwent the same PAE intervention, while the initial PAE group was encouraged to continue community-based self-guided exercise without supervision of the researchers.",fulltext,"After 24 weeks, the waitlist group underwent the same PAE intervention, while the initial PAE group was encouraged to continue community-based self-guided exercise without supervision of the researchers.",100.0
1771,PRECIS-2,"The PAE group underwent supervised high-intensity PAE for 24 weeks, while the waitlist group continued their habitual lifestyle (including ongoing physiotherapy treatment).",fulltext,"The PAE group underwent supervised highintensity PAE for 24 weeks, while the waitlist group continued their habitual lifestyle (including ongoing physiotherapy treatment) ",99.4186046511628
1771,PRECIS-2,"Participants gave written informed consent. The study was approved by the ethical committee of the Central Denmark Region, Denmark (Record No. 1-10-72-291-15).",fulltext,"Participants gave written informed consent. The study was approved by the ethical committee of the Central Denmark Region, Denmark (Record No. 1-10-72-291-15).",100.0
1771,PRECIS-2,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see Langeskov-Christensen et al.",fulltext,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see LangeskovChristensen et al.",99.62264150943396
1771,PRECIS-2,Participants underwent the BRB-N which is a cognitive performance test battery purposely developed to examine cognitive performance in specific cognitive domains in pwMS.,fulltext,Participants underwent the BRB-N which is a cognitive performance test battery purposely developed to examine cognitive performance in specific cognitive domains in pwMS.,100.0
1772,PRECIS-2,"The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15]. This was measured using the Global Satisfaction subscale score on the TSQM v1.4, where higher scores indicate greater satisfaction.",fulltext,"t The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15]. This was measured using the Global Satisfaction subscale score on the TSQM v1.4, where higher scores indicate greater satisfactio",99.38837920489296
1772,PRECIS-2,"For the primary endpoint, enrollment of 1000 patients (750 fingolimod; 250 iDMT) would provide 90% power to detect a significant difference between fingolimod and each iDMT group in the change from baseline, assuming an effect size of 0.25, a significance level of 5% and a 10% rate of unevaluable patients.",fulltext,"For the primary endpoint, enrollment of 1000 patients (750 fingolimod; 250 iDMT) would provide 90% power to detect a significant difference between fingolimod and each iDMT group in the change from baseline, assuming an effect size of 0.25, a significance level of 5% and a 10% rate of unevaluable patients.",100.0
1772,PRECIS-2,"Patients randomized to the iDMT group either remained on the iDMT, or were re-randomized to another approved iDMT. The four iDMTs were subcutaneous (SC) IFN beta-1b (Extavia®, Novartis Pharma AG, Basel, Switzerland, or Betaseron®, Bayer AG, Leverkusen, Germany) 0.25 mg every other day, IM IFN beta-1a (Avonex®, Biogen Idec, Cambridge, MA, USA) 30 μg once weekly, SC IFN beta-1a (Rebif®, Merck Serono, Darmstadt, Germany, and Pfizer Inc., New York City, NY, USA) 22 or 44 μg three times weekly, or SC GA (Copaxone®, Teva Pharmaceutical Industries Ltd, Petah Tikva, Israel) 20 mg once daily.",fulltext,"Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT. The four iDMTs were subcutaneous (SC) IFN beta-1b (Extavia®, Novartis Pharma AG, Basel, Switzerland, or Betaseron®, Bayer AG, Leverkusen, Germany) 0.25 mg every other day, IM IFN beta-1a (Avonex®, Biogen Idec, Cambridge, MA, USA) 30 μg once weekly, SC IFN beta-1a (Rebif®, Merck Serono, Darmstadt, Germany, and Pfizer Inc., New York City, NY, USA) 22 or 44 μg three times weekly, or SC GA (Copaxone®, Teva Pharmaceutical Industries Ltd, Petah Tikva, Israel) 20 mg once dail",97.79661016949153
1772,PRECIS-2,"Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria [14], and an Expanded Disability Status Scale (EDSS) score of 0–5.5 were eligible to participate in the study.",fulltext,"a Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria [14], and an Expanded Disability Status Scale (EDSS) Calkwood et al. BMC Neurology 2014, 14:220 Page 2 of 11 http://www.biomedcentral.com/1471-2377/14/220 score of 0–5.5 were eligible to participate in the stud",99.08256880733946
1772,PRECIS-2,The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15].,fulltext,t The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15,98.97435897435898
1773,PRECIS-2,All subjects taking part in the study (n = 42) completed all the scheduled testing protocols. Adherence to the training intervention (e.g. EG) averaged 92.9 ± 1.5 sessions from a total of 24 planned sessions. All participants from the EG completed more than 75% of the sessions included in the resistance training program.,fulltext,All subjects taking part in the study (n = 42) completed all the scheduled testing protocols. Adherence to the training intervention (e.g. EG) averaged 22.9 ± 1.5 sessions from a total of 24 planned sessions. All participants from the EG completed more than 75% of the sessions included in the resistance training program.,99.68944099378882
1773,PRECIS-2,"Knee extension maximal voluntary isometric contraction (MVIC), muscle endurance and muscle power was evaluated before and after the 12 weeks after training completion. A strain gauge was used to measure the maximal voluntary isometric contraction and muscle power was assessed with a linear encoder. Muscle endurance was interpreted as the number of repetitions that a patient could perform in a single set of knee extension exercise.",fulltext,"Knee extension maximal voluntary isometric contraction (MVIC), muscle power and muscle endurance were evaluated before and after the RTP, as well as 12 weeks after training completion. A strain gauge was used to measure the maximal voluntary isometric contraction and muscle power was assessed with a linear encoder. Muscle endurance was interpreted as the number of repetitions that a patient could perform in a single set of knee extension exercise.",97.23502304147466
1773,PRECIS-2,"The CG followed their habitual daily activities during the study period and they did not follow any kind of structured physical activity. Dependent variables included maximal voluntary isometric contraction (MVIC), maximal torque, average power and muscle endurance.",fulltext,"The CG followed their habitual daily activities during the study period and they did not follow any kind of structured physical activity. Dependent variables included maximal voluntary isometric contraction (MVIC), maximal torque, aver",88.34586466165413
1773,PRECIS-2,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",fulltext,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",100.0
1773,PRECIS-2,"Average power test was also carried out in the knee extension machine described for the training program. Participants were evaluated during a single set to volitional exhaustion with a load corresponding to the 40% of the pre-training MVIC (De Souza-Teixeira, 2009). Subjects were requested to perform the concentric phase of every repetition with a ROM of ∼90–180 degrees, as fast as possible, and to lower the load (eccentric action; ∼180–90°) in a control manner.",fulltext,"Average power test was also carried out in the knee extension machine described for the training program. Participants were evaluated during a single set to volitional exhaustion with a load corresponding to the 40% of the pre-training MVIC (De Souza-Teixeira, 2009). Subjects were requested to perform the concentric phase of every repetition with a ROM of ∼90–180 degrees, as fast as possible, and to lower the load (eccentric action; ∼180–90 ◦ ) in a control manner.",100.0
1773,PRECIS-2,The study was approved by the Research Ethics Committee of the University of Leon.,fulltext,The study was approved by the Research Ethics Committee of the University of Leon.,100.0
1773,PRECIS-2,None of the patients had previous experience with resistance training.,fulltext,None of the patients had previous experience with resistance training.,100.0
1773,PRECIS-2,"All participants were recruited among six MS rehabilitation centers within the region of Castilla y León (Spain). After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",fulltext,"All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain). After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",99.70326409495549
1773,PRECIS-2,All participants were recruited among six MS rehabilitation centers within the region of Castilla y León (Spain).,fulltext,All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain).,99.11504424778761
648,PRECIS-2,The trial was overseen by an independent trial steering committee. An independent data monitoring committee monitored effectiveness and safety annually.,fulltext,The trial was overseen by an independent trial steering commit tee. An independent data monitoring committee monitored effectiveness and safety annually.,100.0
648,PRECIS-2,"There were no restrictions on the type of suture material that could be used, and standard materials to achieve haemostasis were allowed at the discretion of the surgeon.",fulltext,"there were no restrictions on the type of suture material that could be used, and standard measures to achieve haemostasis were employed regardless of the a",82.35294117647058
648,PRECIS-2,"After widespread consultation, five elements of the caesarean section technique were identified as having a variety of approaches used with no clear evidence of any being better than any others.",fulltext,rolled trial that examined five elements of the caesarean section technique in interventi,37.11340206185567
648,PRECIS-2,"The primary outcome was the composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion (>1 unit) up to the 6-week follow-up visit.",fulltext,"The primary outcome was the composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion (>1 unit) up to the 6-week follow-up visit.",100.0
648,PRECIS-2,"The CORONIS Trial Collaborative Group. The CORONIS Trial. International study of caesarean section surgical techniques: a randomised fractional, factorial, unmasked, randomised controlled trial.",fulltext,"0 CORONIS Trial Collaborative Group. The CORONIS Trial. International study of caesarean section surgical techniques: a randomised fractional, factorial",77.83505154639175
648,PRECIS-2,"Between May 20, 2007, and Dec 31, 2010, 15 935 women were recruited. There were no statistically significant differences within any of the intervention pairs for the primary outcome: blunt versus sharp entry risk ratio 1·03 (95% CI 0·91–1·17), exterior versus intra-abdominal repair 0·96 (0·84–1·08), single-layer versus double-layer closure 0·96 (0·85–1·08), closure versus non-closure 1·06 (0·94–1·20), and chromic catgut versus polyglactin-910 0·90 (0·78–1·04).",fulltext,"Between May 20, 2007, and Dec 31, 2010, 15 935 women were recruited. There were no statistically significant differences within any of the intervention pairs for the primary outcome: blunt versus sharp entry risk ratio 1·03 (95% CI 0·91–1·17), exterior versus intra-abdominal repair 0·96 (0·84–1·08), single-layer versus double-layer closure 0·96 (0·85–1·08), closure versus non-closure 1·06 (0·94–1·20), and chromic catgut versus polyglactin-910 0·90 (0·78–1·04).",100.0
648,PRECIS-2,The CORONIS trial is registered with Current Controlled Trials: ISRCTN31089967.,fulltext,The CORONIS trial is registered with Current Controlled Trials: ISRCTN31089967.,100.0
648,PRECIS-2,"All investigators, surgeons, and participants were unmasked to treatment allocation.",fulltext,"All investigators, surgeons, and participants were unmasked to treatment allocation.",100.0
648,PRECIS-2,The primary analysis of the primary outcome was by intention to treat.,prompt,"the analysis of the primary outcome? For example, score 5 for a very pragmatic approach using intention to treat ",85.71428571428572
648,PRECIS-2,"In the analysis of the primary outcome, neonates from multiple births were treated as independent.",fulltext,"In the analysis of neonatal outcomes, neonates from multiple births were treated as independent,",90.81632653061224
648,PRECIS-2,"Eligibility for inclusion as a trial intervention was based on a range of criteria including the clinical importance of resolving the uncertainty for short-term or long-term outcomes, the likelihood of resolving uncertainty, and the feasibility of undertaking the interventions in the participating countries.",fulltext,"Eligibility for inclusion as a trial intervention was based on a range of criteria including the clinical importance of resolving the uncertainty for short-term and long-term Lancet 2013; 382: 234–48 Published Online May 28, 2013 http://dx.doi.org/10.1016/ S0140-6736(13)60441-9 This publication has been corrected. The corrected version first appeared at thelancet.com on July 19, 2013 See Comment page 188 *Investigators listed at end of paper Correspondence to: Prof Peter Brocklehurst, Institute for Women’s Health UCL, Medical School Building, 74 Huntley Street, London WC1E 6AU, UK p.brocklehurst@ucl.ac.uk Articles www.thelancet.com Vol 382 July 20, 2013 235 outcomes, the quality and quantity of available evidence, and the feasibility of undertaking the interventions in the participating countries.",98.05825242718447
648,PRECIS-2,"CORONIS was a pragmatic international 2×2×2×2×2 non-regular fractional, factorial, unmasked, randomised controlled trial that examined five elements of the caesarean section technique in intervention pairs.",fulltext,"CORONIS was a pragmatic international 2×2×2×2×2 non-regular fractional, factorial, unmasked, randomised controlled trial that examined five elements of the caesarean section technique in intervention pairs.",100.0
648,PRECIS-2,"The primary outcome was a composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion of more than 1 unit up to the 6-week follow-up visit.",fulltext,"The primary outcome was a composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion of more than 1 unit of whole blood or packed cells up to the 6-week follow-up visit.",100.0
648,PRECIS-2,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery. Women who did not return at 6 weeks were located and interviewed by telephone or during a home visit.",fulltext,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery. Women who did not return at 6 weeks were located and interviewed by telephone or during a home visit.",100.0
650,PRECIS-2,All the family practices of one regional organisation of GPs (a so-called 'care group') in the North of the Netherlands were eligible to participate in the study. GPs were asked to participate in the SMS project. Their PNs for diabetes care were randomly assigned to an intervention or control arm.,fulltext,All the family practices of one regional organisation of GPs (a so-called ‘care group’) in the South of the Netherlands were eligible to participate in the study. GPs were asked to participate in the SMS project. Their PNs for diabetes care were randomly assigned to an intervention or control arm.,99.32885906040269
650,PRECIS-2,"In European countries, most patients with diabetes receive follow-up care in the primary care setting by nurses.",fulltext,"In European countries, most patients with diabetes receive follow-up care in the primary care setting by nurses.",100.0
650,PRECIS-2,GPs were asked to participate in the SMS project. Their PNs for diabetes care were randomly assigned to an intervention or control arm.,fulltext,GPs were asked to participate in the SMS project. Their PNs for diabetes care were randomly assigned to an intervention or control arm.,100.0
650,PRECIS-2,Analyses were performed on an intention-to-treat basis.,fulltext,Analyses were performed on an intention-to-treat basis.,100.0
650,PRECIS-2,"The starting point was a nurse-led minimal psychological intervention. A previous randomised trial has shown that this intervention was cost-effective for patients with diabetes with minor to moderate depression: 9 months after receiving the intervention, depressive symptoms were significantly lower, there was a positive effect on patients' quality of life, and patients experienced less anxiety, possessed more self-efficacy and demonstrated better glycaemic control and showed more participation in comparison to control patients.",fulltext,"The starting point was a nurse-led minimal psychological intervention. A previous randomised trial has shown that this intervention was cost-effective for patients with diabetes with minor to moderate depression: 9 months after receiving the intervention, depressive symptoms were significantly lower, there was a positive effect on patients’ quality of life, and patients experienced less anxiety, possessed more selfefficacy skills, demonstrated better glycaemic control and showed more participation in comparison to control patients.",99.25093632958801
650,PRECIS-2,"The glycaemic control of patients was measured during consultations. For the baseline measure, we used data from the first consultation after the patient's baseline measurement (maximum interval of 3 months). The consultation following this first consultation was used as the 4-month follow-up measurement.",fulltext,"The glycated haemoglobin in mmol/mol was measured during consultations. For the baseline measure, we used data from the first consultation after the patient’s baseline measurement (with a maximum interval of 3 months). The consultation following this first consultation was used as the 4-month follow-up measurement.",95.09803921568627
650,PRECIS-2,"SMS included a detection and follow-up phase. The flow chart of SMS is presented in figure 1. The detection phase of SMS started by exploring whether a patient experienced problems in daily life. PNs then applied the DFT by showing patients a vertical line ranging from 0 to 10 with 0 indicating no burden at all and 10 indicating extreme burden, and asking them to rate the burden of diabetes in their daily life.",fulltext,"SMS included a detection and follow-up phase. The flow chart of SMS is presented in figure 1. The detection phase of SMS started by exploring whether a patient experienced problems in daily life. PNs then applied the DFT by showing patients a vertical line ranging from 0 to 10 with 0 indicating no burden at all and 10 indicating extreme burden, and asking them to rate the burden of diabetes in their daily life.",100.0
650,PRECIS-2,The effect of SMS on patients' daily functioning was measured by means of the DFT. The DFT was dichotomised to compare the number of patients who were improved in their daily functioning and had apparently found a satisfactory way to live with the consequences of their diabetes (DFT ≤4) with patients who still perceived a burden of diabetes on their daily functioning (DFT >4).,fulltext,"The effect of SMS on patients’ daily functioning was measured by means of the DFT. The DFT was dichotomised to compare the number of patients who were improved in their daily functioning and had apparently found a van Dijk-de Vries A, et al. BMJ Open 2015;5:e007014. doi:10.1136/bmjopen-2014-007014 3 Open Access on July 17, 2023 at University of Basel. Protected by copyright. http://bmjopen.bmj.com/ BMJ Open: first published as 10.1136/bmjopen-2014-007014 on 25 June 2015. Downloaded from satisfactory way to live with the consequences of their diabetes (DFT ≤4) with patients who still perceived a burden of diabetes on their daily functioning (DFT >4).",100.0
651,PRECIS-2,"We randomly assigned patients to 2 years of open-label therapy, under the care of their usual physician, with LTRA (148 patients) or an inhaled glucocorticoid (135 patients) as the first-line controller therapy trial and LTRA (170 patients) or LABA (182 patients) added to an inhaled glucocorticoid in the add-on therapy trial.",fulltext,"We randomly assigned patients to 2 years of open-label therapy, under the care of their usual physician, with LTRA (148 patients) or an inhaled glucocorticoid (158 patients) in the first-line controller therapy trial and LTRA (170 patients) or LABA (182 patients) added to an inhaled glucocorticoid in the add-on therapy trial.",99.08256880733946
651,PRECIS-2,"We conducted two parallel, multicenter, pragmatic trials to evaluate the real-world effectiveness of a leukotriene-receptor antagonist (LTRA) as compared with either an inhaled glucocorticoid for first-line asthma-controller therapy or a long-acting beta2-agonist (LABA) as add-on therapy in patients already receiving inhaled glucocorticoid therapy.",fulltext,"We conducted two parallel, multicenter, pragmatic trials to evaluate the real-world effectiveness of a leukotriene-receptor antagonist (LTRA) as compared with either an inhaled glucocorticoid for first-line asthma-controller therapy or a long-acting beta 2 agonist (LABA) as add-on therapy in patients already receiving inhaled glucocorticoid therapy.",100.0
651,PRECIS-2,"Other eligibility criteria for both trials included, at screening, a peak expiratory flow (PEF) greater than 50% of the predicted value after an inhaled beta2-agonist had been withheld for 4 hours or longer and, at the baseline visit, evidence of impaired asthma-related quality of life (a score ≤6 on the Mini Asthma Quality of Life Questionnaire25,26 [MiniAQLQ]) or impaired asthma control (a score ≥1 on the Asthma Control Questionnaire27 [ACQ]).",fulltext,"Other eligibility criteria for both trials included, at screening, a peak expiratory flow (PEF) greater than 50% of the predicted value after an inhaled beta 2 -agonist had been withheld for 4 hours or longer and, at the baseline visit, evidence of impaired asthma-related quality of life (a score ≤6 on the Mini Asthma Quality of Life Questionnaire 25,26 [MiniAQLQ]) or impaired asthma control (a score ≥1 on the Asthma Control Questionnaire 27 [ACQ]).",100.0
651,PRECIS-2,"Double-blind treatment, although ideal for internal validity, would have severely affected the external validity (applicability) of this study. First, not revealing treatment assignments to the patients and health care providers would have hampered our goal of assessing the effect of differential adherence to oral versus inhaled therapy under conditions of usual patient and physician behaviors and preferences.",fulltext," Double-blind treatment, although ideal for internal validity, would have severely affected the external validity (applicability) of this study. First, not revealing treatment assignments to the patients and health care providers would have hampered our goal of assessing the effect of differential adherence to oral versus inhaled therapy under conditions of usual patient and physician behaviors and preferences",99.75786924939467
651,PRECIS-2,Eligible primary care patients 12 to 80 years of age had impaired asthma-related quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,fulltext,Eligible primary care patients 12 to 80 years of age had impaired asthmarelated quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,99.57627118644068
651,PRECIS-2,"The primary outcome measure was the MiniAQLQ score.25,26 Secondary outcome measures included the ACQ score27; the score on the not-yet-validated Royal College of Physicians 3-item asthma questionnaire (RCP3) (range of scores, 0 to 3, with higher scores indicating worse asthma control)30; the score on the validated 14-item Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) (range of scores, 0 to 6, with higher scores indicating worse rhinitis-related impairment and with an MID of 0.7)31; and the frequency of asthma exacerbations, which were defined as the need for an oral course of glucocorticoids or hospitalization for asthma.",fulltext,"The primary outcome measure was the MiniAQLQ score. 25,26 Secondary outcome measures included the ACQ score 27 ; the score on the not-yet-validated Royal College of Physicians 3-item asthma questionnaire (RCP3) (range of scores, 0 to 3, with higher scores indicating worse asthma control) 30 ; the score on the validated 14-item Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) (range of scores, 0 to 6, with higher scores indicating worse rhinitis-related impairment and with an MID of 0.7) 31 ; and the frequency of asthma exacerbations, which were defined as the need for an oral course of glucocorticoids or hospitalization for asthma.",100.0
651,PRECIS-2,"The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years. Analysis of covariance was used, with treatment as a fixed effect and the baseline value as a covariate. A 95% confidence interval (CI) was derived for the adjusted difference between mean scores.",fulltext,"The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years. Analysis of covariance was used, with treatment The New England Journal of Medicine Downloaded from nejm.org at University of Basel on July 17, 2023. For personal use only. No other uses without permission. Copyright © 2011 Massachusetts Medical Society. All rights reserved. T h e n e w e ng l a nd j o u r na l o f m e dic i n e n engl j med 364;18 nejm.org may 5, 2011 1698 as a fixed effect and the baseline value as a covariate. A 95% confidence interval (CI) was derived for the adjusted difference between mean scores.",100.0
651,PRECIS-2,The post hoc per-protocol results approached but did not meet equivalence for the effect on the MiniAQLQ score at 2 months and 2 years (Table 2). ACQ scores did not differ significantly between the LTRA and inhaled-glucocorticoid groups (Table E17 in the Supplementary Appendix).,fulltext,The post hoc per-protocol results approached but did not meet equivalence for the effect on the MiniAQLQ score at 2 months and 2 years ( Table 2). ACQ scores did not differ significantly between the LTRA and inhaled-glucocorticoid Table 1. Baseline Characteristics of the Patients,89.24731182795699
651,PRECIS-2,"At 2 months and 2 years, the adjusted 95% CI for the difference in the MiniAQLQ scores was just outside the equivalence limit of 0.3 (Table 2 and Fig. 1). The MiniAQLQ domain scores are summarized in Table E15 in the Supplementary Appendix.",fulltext," at 2 months, whereas at 2 years, the adjusted 95% CI for the difference in the MiniAQLQ scores was just outside the equivalence limit of 0.3 ( Table 2 and Fig. 1). The MiniAQLQ domain scores are summarized in Table E15 in the Supplementary Append",97.91666666666666
651,PRECIS-2,"An automated, computerized telephone center randomly assigned eligible patients to a baseline visit.",fulltext,"An automated, computerized telephone center randomly assigned eligible patients at baseline ",91.0
655,PRECIS-2,"Patients were instructed to report any adverse events and medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",fulltext,"patient was assessed, medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",82.70042194092827
655,PRECIS-2,Patients were provided with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session,fulltext, with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session,88.65979381443299
655,PRECIS-2,"A patient in the IG arm was classified as a non-complier if he/she did not perform scheduled exercises for at least 8 consecutive weeks, unless there were clear clinical reasons not to.",fulltext," patient in the IG arm was classified as a non-complier if he/she did not perform scheduled exercises for at least 8 consecutive weeks, unless there were clear clinical reasons not to.",99.45945945945947
655,PRECIS-2,"At each visit, patients were advised to continue maintenance exercises supporting the intention-to-treat principle",fulltext,"At each visit, patients were advised to continue doing exercise and attending follow-up appointments even if they decided not to comply with the assigned maintenance exercises, supporting the intention-to-treat principle",100.0
655,PRECIS-2,Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital.,fulltext,Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital.,100.0
655,PRECIS-2,"Continuous variables are described using either the mean and standard deviation or the median and range, depending on the data distribution. Categorical variables are described using frequencies and percentages. The main efficacy analysis used analysis of covariance (ANCOVA) techniques to test for differences between groups in outcome variables at the 12-month visit, adjusted for baseline values.",fulltext,"Continuous variables are described using either the mean and standard deviation or the median and range, depending on the data distribution. Categorical variables are described using frequencies and percentages. The main efficacy analysis used analysis of covariance (ANCOVA) techniques to test for differences between groups in outcome variables at the 12-month visit, adjusted for baseline values.",100.0
655,PRECIS-2,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017.,fulltext,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017,99.32432432432432
655,PRECIS-2,"Lastly, BODE scores were calculated at each follow-up visit for the IG and at baseline and 12-month visits for the CG.",fulltext,"Lastly, BODE scores were calculated at each follow-up visit for the IG and at baseline and 12-month visits for the CG.",100.0
655,PRECIS-2,This was a multicentre open-label pragmatic parallel-group randomized clinical trial conducted. Two groups were created at completion of an 8-week intensive outpatient hospital PR programme.,fulltext, A multicentre open-label pragmatic parallel-group randomized clinical trial was conducted. Two groups were created at completion of an 8-week intensive outpatient hospital PR programme.,95.78947368421052
655,PRECIS-2,The primary outcome was the change in the 6-min walk distance (6MWD) in the intervention arm (IG) compared to the control arm (CG).,fulltext, Change Over Time in the 6-Minute Walk Test Distance ,28.24427480916031
655,PRECIS-2,Patients in the control group (CG) were advised to exercise regularly (usual care).,fulltext,Patients in the control group (CG) were advised to exercise regularly (usual care).,100.0
657,PRECIS-2,The physical therapists had varied experience in MS treatment as well as the theoretical framework for the intervention.,fulltext,"The physical therapists received a booklet with descriptions and photos of all exercises and variations, as well as the theoretical framework for the intervention.",85.83333333333334
657,PRECIS-2,"In August 2015, 1 of the 6 municipalities included in the study sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic.",fulltext,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic,",89.61748633879782
657,PRECIS-2,Participants in both groups were encouraged to continue their usual medical treatment.,fulltext,Participants in both groups were encouraged to continue their usual medical treatment.,100.0
657,PRECIS-2,"Assessments were undertaken at baseline and at weeks 7, 18, and 30. Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance. Repeated-measures mixed models were used for statistical analysis.",fulltext,"Assessments were undertaken at baseline and at weeks 7, 18, and 30. Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance. Repeated-measures mixed models were used for statistical analysis.",100.0
657,PRECIS-2,The primary outcome was balance and trunk control in individuals with MS.,fulltext,n balance and trunk control in individuals with MS.,68.49315068493152
657,PRECIS-2,"At enrollment, all participants underwent a clinical examination by a neurologist (F.O.) to assess their EDSS scores and review their medical history, noting the type of MS, age, sex, weight, height, and medications.",fulltext,"At enrollment, all participants underwent a clinical examination by a neurologist (F.O.) to assess their EDSS scores and review their medical history, noting the type of MS, age, sex, weight, height, and medications.",100.0
657,PRECIS-2,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,fulltext,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,100.0
657,PRECIS-2,"One individual missed all postintervention tests, leaving 79 participants in the intention-to-treat analysis.",fulltext,"One individual missed all postintervention tests, leaving 79 participants in the intention-to-treat analysis.",100.0
657,PRECIS-2,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days. The training included practical and theoretical training.,fulltext,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days. The training included practical and theoretical training.,100.0
657,PRECIS-2,"Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance.",fulltext,"Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance.",100.0
657,PRECIS-2,"The physical therapists chose from 33 exercises, all with 5 levels of difficulty to address each individual's impairments underlying his or her balance disturbance.",fulltext,"The physical therapists chose from 33 exercises, all with 5 levels of difficulty to address each individual's impairments underlying his or her balance disturbance.",100.0
657,PRECIS-2,All group members received a booklet with illustrations of the exercises to be conducted twice per week for 30 minutes.,fulltext,All group members received a booklet with illustrations of the exercises in which the physical therapist prescribed unsupervised home exercises to be conducted twice per week for 30 minutes.,100.0
657,PRECIS-2,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway. Standard care included the usual care in individuals with MS in the same municipalities. Assessments at all time points took place at a Norwegian hospital.,fulltext,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway. Standard care included the usual care for individuals with MS in the same municipalities. Assessments at all time points took place at a Norwegian hospital.,99.21875
662,PRECIS-2,"Fifty were excluded, and three declined to be randomised.",fulltext,"Fifty were excluded, and three declined to be randomised.",100.0
662,PRECIS-2,"Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M)19 and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10).20",fulltext,"Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M) 19 and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10). 2",99.64788732394366
662,PRECIS-2,The remaining 18 participants continued participating in the mindfulness course until the end of the intervention. All the participants attended four or more of the eight mindfulness sessions and 14 (73.7%) attended six or more sessions.,fulltext,The remaining 18 participants continued participating in the mindfulness course until the end of the intervention. All the participants attended four or more of the eight mindfulness sessions and 14 (73.7%) attended six or more sessions.,100.0
662,PRECIS-2,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,fulltext,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,100.0
662,PRECIS-2,"The format and manual for the mindfulness group, including length of sessions and individual mindfulness practices, were developed in partnership with patients with MS through initial experimental case studies. The content of the manual was adapted from the Mindfulness-Based Cognitive Therapy (MBCT) course book.22",fulltext,"The format and manual for the mindfulness group, including length of sessions and individual mindfulness practices, were developed in partnership with patients with MS through initial experimental case studies. The content of the manual was adapted from the Mindfulness-Based Cognitive Therapy (MBCT) course book. ",99.36507936507937
662,PRECIS-2,"Of the 40 randomised participants, 17 (42%) had PPMS, and 23 (57.5%) had SPMS. The overall sample was 55% female, predominantly white British (90%), with a mean age of 52.7 years (SD = 9.5), with the majority married or cohabiting (77.5%). Median time since diagnosis was 12.0 years (range = 1–38).",fulltext,"Of the 40 randomised participants, 17 (42%) had PPMS, and 23 (57.5%) had SPMS. The overall sample was 55% female, predominantly white British (90%), with a mean age of 52.7 years (SD = 9.5), with the majority married or cohabiting (77.5%). Median time since diagnosis was 12.0 years (range = 1–38).",100.0
662,PRECIS-2,"Participants completed standardised questionnaires to measure mood, impact of MS and symptom severity, quality of life and service costs at baseline, post-intervention and three-month follow-up.",fulltext,"Participants completed standardised questionnaires to measure mood, impact of MS and symptom severity, quality of life and service costs at baseline, post-intervention and threemonth follow-up.",99.48453608247422
662,PRECIS-2,"The treatment phase took place between February 2013 and July 2013. We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences. We restricted the number of participants to five for each group based on a Skype user guidance, which suggests the quality of videoconferences drops with more than this number.21 Participants were sent a headset and webcam together with instructions of how to set up Skype.",fulltext,"The treatment phase took place between February 2013 and July 2013. We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences. We restricted the number of participants to five for each group based on Skype user guidance, which suggests the quality of videoconferences drops with more than this number. 21 Participants were sent a headset and webcam together with instructions of how to set up Skype.",99.55654101995566
662,PRECIS-2,The GHQ12 is designed to measure general levels of distress. The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS.26 Higher scores on this scale represent high distress.,fulltext,The GHQ 17 is designed to measure general levels of distress. The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS. 26 Higher scores on this scale represent high distress.,99.6268656716418
662,PRECIS-2,"Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone. Inclusion criteria were the presence of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).17",fulltext,"Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone. Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12). 1",96.01328903654485
663,PRECIS-2, section) and targeted advertisements sent out via the Danish MS Society.,fulltext, section) and targeted advertisements sent out via the Danish MS Society.,100.0
663,PRECIS-2,The Six Minute Walk26 assessed gait distance and was conducted on a 30-m walkway. The ,fulltext,The Six Minute Walk 26 assessed gait distance and was conducted on a 30-m walkway. The ,100.0
663,PRECIS-2,"The exercises were conducted in machines that targeted the specified muscle groups, but type of machines could vary between centers. All training sessions were supervised by physiotherapists who were trained to deliver the intervention.",fulltext,"The exercises were conducted in machines that targeted the specified muscle groups, but type of machines could vary between centers. All training sessions were supervised by physiotherapists who were trained to deliver the intervention.",100.0
663,PRECIS-2,The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,fulltext,The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,100.0
663,PRECIS-2,"Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT and BMCT and PRT lasting the last 3 months.",fulltext,"Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",92.62672811059907
663,PRECIS-2,Groups of 3–6 patients were referred to physiotherapy clinics that were randomly assigned to provide either PRT or BMCT or to a waitlist CON. Allocation of interventions was done by a cluster randomization conducted whenever a sufficient number of patients were established at three different participating clinics.,fulltext,Groups of 3–6 patients were referred to physiotherapy clinics that were randomly assigned to provide either PRT or BMCT or to a waitlist CON. Allocation of interventions was done by a cluster randomization conducted whenever three groups could be established at three different participating clinics.,91.11111111111111
663,PRECIS-2,"Physiotherapists with experience in providing BMCT managed the programs. The therapists were instructed to aim for a level of difficulty, where the participants experienced failure but still reached successful execution in more than 50% of the attempts/time.",fulltext,"Physiotherapists with experience in providing BMCT managed the programs. The therapists were instructed to aim for a level of difficulty, where the participants experienced failure but still reached successful execution in more than 50% of the attempts/time.",100.0
663,PRECIS-2,The primary outcomes were walking speed assessed by the T25FW20 and complex walking assessed by the SSST.21 Both outcomes were obtained at the fastest safe walking speed and conducted in accordance with the original descriptions.,fulltext,The primary outcomes were walking speed assessed by the T25FW 20 and complex walking assessed by the SSST. 21 Both outcomes were obtained at the fastest safe walking speed and conducted in accordance with the original descriptions.,100.0
663,PRECIS-2,The BMCT intervention consisted of 20 1-hour training sessions over 10 weeks (two sessions/ week). All sessions started with a 10-minute warm-up on a stationary bicycle or treadmill.,fulltext,The BMCT intervention consisted of 20 1-hour training sessions over 10 weeks (two sessions/ week). All sessions started with a 10-minute warm-up on a stationary bicycle or treadmill.,100.0
663,PRECIS-2, (ABC) questionnaire was used to assess balance confidence.27,fulltext, (ABC) questionnaire was used to assess balance confidence. ,96.72131147540983
663,PRECIS-2," section) and targeted advertisements sent out via the Danish MS Society. The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",fulltext," section) and targeted advertisements sent out via the Danish MS Society. The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",100.0
663,PRECIS-2,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in ",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in ",100.0
663,PRECIS-2,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention. Carry forward imputations were not used to replace missing data in the primary intention to treat analysis.",fulltext,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention. Carry forward imputations were not used to replace missing data in the primary intention to treat analysis.",100.0
664,PRECIS-2,"Outcomes were assessed at baseline, and at three months (post-intervention) and nine months after randomisation. The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).14 The GLTEQ asks participants to recall the frequency of strenuous, moderate and mild intensity exercise for periods >15 minutes over the past seven days and is a valid measure of habitual exercise in PwMS.15 Daily movement and step counts were objectively assessed using an accelerometer (Actigraph GT2M accelerometer, Actigraph, LLC, FL, USA), worn on the waist during waking hours, except when bathing/showering or swimming.",fulltext,"Outcomes were assessed at baseline, and at three months (post-intervention) and nine months after randomisation. The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ). 14 The GLTEQ asks participants to recall the frequency of strenuous, moderate and mild intensity exercise for periods >15 minutes over the past seven days and is a valid measure of habitual exercise in PwMS. 15 Daily movement and step counts were objectively assessed using an accelerometer (Actigraph GT2M accelerometer, Actigraph, LLC, FL, USA), worn on the waist during waking hours, except when bathing/showering or swimming.",100.0
664,PRECIS-2,"The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).14 The GLTEQ asks participants to recall the frequency of strenuous, moderate and mild intensity exercise for periods >15 minutes over the past seven days and is a valid measure of habitual exercise in PwMS.15",fulltext,"The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ). 14 The GLTEQ asks participants to recall the frequency of strenuous, moderate and mild intensity exercise for periods >15 minutes over the past seven days and is a valid measure of habitual exercise in PwMS. 1",99.70760233918129
664,PRECIS-2,Participants in the usual care group were offered three exercise sessions at the university research facility and individual exercise advice after the study.,fulltext,Participants in the usual care group were offered three exercise sessions at the university exercise research facility and individual exercise advice after the study.,100.0
664,PRECIS-2,"A total of 13 participants (six from the intervention group and seven from the usual care group) were lost to follow-up at three months. An additional eight participants were lost to follow-up at nine months (five from the intervention group and three from the usual care group; Figure 1). Participants who dropped out of the study were slightly younger than the study completers (43.3 vs 46.3 years) and had higher baseline EDSS and total fatigue scores (4.5 vs 3.6 and 48.0 vs 42.6, respectively). During the nine-month study period, 16 MS relapses were experienced by 14 of the usual care participants in comparison to 10 MS relapses experienced by nine participants in the exercise group. Participants were encouraged to rejoin the trial following recovery, and complete or partial follow-up data were obtained for 21 of the 23 relapsing participants.",fulltext,"A total of 13 participants (six from the intervention group and seven from the usual care group) were lost to follow-up at three months. An additional eight participants were lost to follow-up at nine months (five from the intervention group and three from the usual care group; Figure 1). Participants that dropped out of the study were slightly younger than the study completers (43.3 vs 46.3 years) and had higher baseline EDSS and total fatigue scores (4.5 vs 3.6 and 48.0 vs 42.6, respectively). During the nine-month study period, 16 MS relapses were experienced by 14 of the usual care participants in comparison to 10 MS relapses experienced by nine participants in the exercise group. Participants were encouraged to rejoin the trial following recovery, and complete or partial follow-up data were obtained for 21 of the 23 relapsing participants.",99.76608187134502
664,PRECIS-2,"Adherence to the supervised and home-exercise sessions was very good, with participants attending an average of 16.2 of the 18 supervised sessions (90%; range 7–18 sessions) and participating in an average of 14.6 of the 18 prescribed home-exercise sessions (81%, range 2–18 sessions).",fulltext,"Adherence to the supervised and home-exercise sessions was very good, with participants attending an average of 16.2 of the 18 supervised sessions (90%; range 7–18 sessions) and participating in an average of 14.6 of the 18 prescribed home-exercise sessions (81%, range 2–18 sessions).",100.0
664,PRECIS-2,"An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme. During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",fulltext,"An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme. During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",100.0
664,PRECIS-2,"PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches. All patients were assessed by a consultant neurologist with an interest in MS prior to entering the trial. The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria,9 with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",fulltext,"PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches. All patients were assessed by a consultant neurologist with an interest in MS prior to entering the trial. The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, 9 with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",100.0
664,PRECIS-2,PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,fulltext,PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,100.0
664,PRECIS-2,"Supervised exercise sessions involved up to three participants and lasted for approximately one hour. Studies show that aerobic exercise, resistance exercise and combined programmes bring health benefits to PwMS.10,11 Hence, the programme was designed to be pragmatic and accessible, taking into account exercise preferences and giving choices.",fulltext,"Supervised exercise sessions involved up to three participants and lasted for approximately one hour. Studies show that aerobic exercise, resistance exercise and combined programmes bring health benefits to PwMS. 10,11 Hence, the programme was designed to be pragmatic and accessible, taking into account exercise preferences and giving choices.",100.0
665,PRECIS-2,"The collection of outcome data by postal questionnaire proved to be challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.",fulltext,"The collection of outcome data by postal questionnaire proved to be challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.",100.0
665,PRECIS-2,"The study statisticians and principal investigator remained blinded to the treatment allocation codes until after the final analysis. Blinding the Blues® consists of eight computer-interactive sessions, of approximately 50 minutes each in duration, designed to be taken weekly. Each session consists of a mix of cognitive and behavioural strategies, which the user customises to their individual problems.",fulltext,"The study statisticians and principal investigator remained blinded to the treatment allocation codes until after the final analysis. Beating the Blues ® consists of eight computer-interactive sessions, of approximately 50 minutes each in duration, designed to be taken weekly. Each session consists of a mix of cognitive and behavioural strategies, which the user customises to their individual problems.",99.01234567901234
665,PRECIS-2,Participants were recruited through out-patient clinics and postal screening questionnaires at two UK centres and randomised to CCBT or usual care.,fulltext,Participants with a diagnosis of MS and clinical levels of depression were recruited through out-patient clinics and postal screening questionnaires at two UK centres and randomised to CCBT or usual care.,100.0
665,PRECIS-2,"Delivery of CCBT (home/external) and variation in delivery and use In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring (PCTs were publicly funded organisations responsible for commissioning acute services for local populations). The CCBT service provided to trial participants was the routine service configuration.",fulltext,"Delivery of CCBT (home/external) and variation in delivery and use In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring (PCTs were publicly funded organisations responsible for commissioning acute services for local populations). The CCBT service provided to trial participants was the routine Pati",95.42168674698796
665,PRECIS-2,"Of the 12 patients in the CCBT arm, 9 (75%) completed at least four CCBT sessions. This translated to a reasonably high compliance rate of CCBT although only six (50%) of the patients in this arm completed all intended eight CCBT sessions.",fulltext,"Of the 12 patients in the CCBT arm, 9 (75%) completed at least four CCBT sessions. This translated to a reasonably high compliance rate of CCBT although only six (50%) of the patients in this arm completed all intended eight CCBT sessions.",100.0
665,PRECIS-2,Participants with a diagnosis of MS and clinical levels of depression were recruited through out-patient clinics and postal screening questionnaires at two UK centres and randomised to CCBT or usual care.,fulltext,Participants with a diagnosis of MS and clinical levels of depression were recruited through out-patient clinics and postal screening questionnaires at two UK centres and randomised to CCBT or usual care.,100.0
665,PRECIS-2,"Follow up time points: 0 weeks, 8 weeks, 21 weeks",fulltext,Follow up Time point,40.816326530612244
665,PRECIS-2,"The pre-specified primary outcome was the recruitment rate, calculated as the proportion of those invited to fill in a screening questionnaire who consented into the trial.",fulltext,"The pre-specified primary outcome was the recruitment rate, calculated as the proportion of those invited to fill in a screening questionnaire who were consented into the trial.",100.0
665,PRECIS-2,"Twenty-four participants were recruited. The recruitment rate, calculated as the proportion of those invited to fill in a screening questionnaire who consented into the trial, was 4.1%.",fulltext,"Twenty-four participants were recruited. The recruitment rate, calculated as the proportion of those invited to fill in a screening questionnaire who were consented into the trial, was 4.1%.",100.0
665,PRECIS-2,"Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non-compliance, protocol deviations and withdrawal.",fulltext,"Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non compliance, protocol deviations and withdrawal.",100.0
666,PRECIS-2,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",fulltext,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",100.0
666,PRECIS-2,"The intention-to-treat (ITT) analysis set included all randomly assigned patients and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received.",fulltext,"The intention-to-treat (ITT) analysis set included all randomly assigned participants and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received.",99.55357142857143
666,PRECIS-2,"Safety assessments were recorded in clinic visits and included adverse events (AEs) throughout the study, vital sign measurements, concomitant medication usage, and clinical laboratory test results at screening and Months 1, 3, and 6. Safety variables monitored also included the percentage of early treatment discontinuation patients who prematurely discontinued from the study due to AEs, as well as the time to withdrawal.",fulltext,"Safety assessments were recorded in clinic visits and included adverse events (AEs) throughout the study, vital sign measurements, concomitant medication usage, and clinical laboratory test results at screening and Months 1, 3, and 6. Safety variables monitored also included the percentage of early treatment discontinuation patients who prematurely discontinued from the study due to AEs, as well as the time to withdrawal.",100.0
666,PRECIS-2,"The intention-to-treat (ITT) analysis set included all randomly assigned patients and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received. Patient-reported endpoints were analyzed based on the full analysis set (FAS), which included all patients in the ITT population who received at least 1 dose of study drug and had at least 1 post-baseline assessment. Safety analyses were performed on the safety analysis set, which included all patients who received at least 1 dose of a study drug.",fulltext,"The intention-to-treat (ITT) analysis set included all randomly assigned participants and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received. Patient-reported endpoints were analyzed based on the full analysis set (FAS), which included all patients in the ITT population who received at least 1 dose of study drug and had at least 1 post-baseline assessment. Safety analyses were performed on the safety analysis set, which included all patients who received at least 1 dose of a study drug.",99.82578397212544
666,PRECIS-2,"Patients' adherence to treatment measured at Months 1, 3, and 6 using the MS-TAQ questionnaire showed consistently greater adherence to treatment in patients receiving GA40 compared with those receiving GA20 (Fig. 5). RM ANOVA analyses of MS-TAQ total scores during the 6-month treatment period showed significantly lower MS-TAQ scores in patients treated with GA40 than with GA20 during that time, indicating higher adherence to GA40 versus GA20 (table e-4).",fulltext,"Patients' adherence to treatment measured at Months 1, 3, and 6 using the MS-TAQ questionnaire showed consistently greater adherence to treatment in patients receiving GA40 compared with those receiving GA20 (Fig. 5). RM ANOVA analyses of MS-TAQ total scores during the 6-month treatment period showed significantly lower MS-TAQ scores in patients treated with GA40 than with GA20 during that time, indicating higher adherence to GA40 versus GA20 (table e-4).",100.0
666,PRECIS-2,"Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria) (Polman et al., 2011), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.",fulltext,"Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria) (Polman et al., 2011), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.",100.0
666,PRECIS-2,Patients withdrawn (n=32) Death (n=1) Adverse event (n=14) Withdrawal by patient (n=10) Protocol violation (n=1) Lost to follow-up (n=2) Other (n=4),fulltext,Patients with treatment-emergent adverse event,22.297297297297302
668,PRECIS-2,"Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic.",fulltext,"Participants were recruited through a statewide organization providing education and support to people with Dodd et al. 1363 MS, and a large specialist MS outpatient clinic.",100.0
668,PRECIS-2,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",fulltext,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",100.0
668,PRECIS-2,"To determine sample size, power analysis was completed using data from a pilot study. Based on the most conservative of the walking performance effect sizes from that study (d = 0.75, the 2MWT), with a power of 0.80, a sample size of 35 participants was required in each group to detect a difference between groups.",fulltext,"To determine sample size, power analysis was completed using data from a pilot study. 13 Based on the most conservative of the walking performance effect sizes from that study (d ¼ 0.75, the 2MWT), with power of 0.80, a sample size of 35 participants was required in each group to detect a difference between groups.",99.04761904761905
668,PRECIS-2,"All exercises were completed on weight machines. The training intensity was based on a percentage of the 12-repetition maximum (that is, only 12 consecutive repetitions of each exercise could be completed before muscle fatigue was reached). The training protocol was increased when two sets of 12 repetitions of an exercise could be completed.",fulltext,"All exercises were completed on weight machines. The training intensity was based on recommendations of the American College of Sports Medicine (2009) 7 and consisted of two sets of 10–12 repetitions of each exercise, at a training intensity of 10–12 repetition maximum (that is, only 12 consecutive repetitions of each exercise could be completed before muscle fatigue was reached). The weight lifted was increased when two sets of 12 repetitions of an exercise could be completed.",95.33527696793003
668,PRECIS-2,"Participants attended 92% of training sessions, with no serious adverse events. At 10 weeks, no differences were detected in walking performance. However, compared with the comparison group PRT demonstrated increased leg press strength (16.8%, SD 4.5), increased reverse leg press strength (29.8%, SD 12.7), and increased muscle endurance of the reverse leg press (38.7%, SD 32.8).",fulltext,"Participants attended 92% of training sessions, with no serious adverse events. At 10 weeks, no differences were detected in walking performance. However, compared with the comparison group PRT demonstrated increased leg press strength (16.8%, SD 4.5), increased reverse leg press strength (29.8%, SD 12.7), and increased muscle endurance of the reverse leg press (38.7%, SD 32.8).",100.0
668,PRECIS-2,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",fulltext,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",100.0
668,PRECIS-2,Changes in walking endurance were measured with the 2MWT.,fulltext,Changes in walking endurance were measured with the 2,92.98245614035088
668,PRECIS-2,The exercises targeted the key lower limb muscles for supporting body weight and for generating and absorbing power during walking (Table 1).,fulltext,The exercises targeted the key lower limb muscles for supporting body weight and for generating and absorbing power during walking (Table 1).,100.0
668,PRECIS-2,"Changes in muscle strength were determined by the amount of weight that could be lifted in a single seated leg press (1RM, 1 repetition maximum) and a single reverse leg press (resistance of the combined movement of hip flexion, knee flexion and ankle dorsiflexion) (1RM). In adults with MS, a single 1RM leg press has been measured with high levels of retest reliability (r > 0.93).",fulltext,"Changes in muscle strength were determined by the amount of weight that could be lifted in a single seated leg press (1RM, 1 repetition maximum) and a single reverse leg press (resistance of the combined movement of hip flexion, knee flexion and ankle dorsiflexion) (1RM). In adults with MS, a single 1RM leg press has been measured with high levels of retest reliability (r > 0.93).",100.0
668,PRECIS-2,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",fulltext,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score 19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",100.0
668,PRECIS-2,Analysis was completed without Bonferroni adjustment because we decided that this would have resulted in a risk of missing real effects (type II errors) and the consequences of any type I errors would not lead to any negative effects on participants.,fulltext,Analysis was completed without Bonferroni adjustment because we decided that this would have resulted in a risk of missing real effects (type II errors) and the consequences of any type I errors would not lead to any negative effects on participants.,100.0
669,PRECIS-2,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport. Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.",fulltext,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport. Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.",100.0
669,PRECIS-2,"Exclusion criteria were reports of cardiovascular contra-indications, logistic problem or Automated segmentation of MRI.",fulltext,Exclusion criteria were reports ,26.66666666666667
669,PRECIS-2,"Participants who completed the training program showed high adherence. The EXP group completed 607 of 648 prescribed sessions (94%). In all, 25 of 41 missed training sessions were related to training-related complaints, such as repetitive strain injury of the ankle (n=2; 9 sessions), training-related fatigue (n=2; 7 sessions), hip and groin pain (n=1; 6 sessions), and calf muscle strain (n=1; 3 sessions). The remaining missed sessions were caused by external factors such as work, holiday, and flu.",fulltext,"Participants who completed the training program showed high adherence. The EXP group completed 607 of 648 prescribed sessions (94%). In all, 25 of 41 missed training sessions were related to trainingrelated complaints, such as repetitive strain injury of the ankle (n = 2; 9 sessions), training-related fatigue (n = 2; 7 sessions), hip and groin pain (n = 1; 6 sessions), and calf muscle strain (n = 1; 3 sessions). The remaining missed sessions were caused by external factors such as work, holiday, and flu.",99.800796812749
669,PRECIS-2,"Aerobic capacity was assessed on an electronically braked cycle ergometer (eBike Basic®; General Electric GmbH, Bitz, Germany) with continuous pulmonary gas exchange analysis (Oxycon, Erich Jaeger GmbH, Germany), and heart rate (HR) monitoring (Polar®). Oxygen uptake (VO2), expiratory volume, and respiratory exchange ratio were collected breath-by-breath and averaged every minute.",fulltext,"Aerobic capacity was assessed on an electronically braked cycle ergometer (eBike Basic ® ; General Electric GmbH, Bitz, Germany) with continuous pulmonary gas exchange analysis (Oxycon, Erich Jaeger GmbH, Germany), and heart rate (HR) monitoring (Polar ® ). Oxygen uptake (VO 2 ), expiratory volume, and respiratory exchange ratio were collected breath-by-breath and averaged every minute.",100.0
669,PRECIS-2,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",fulltext,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",100.0
669,PRECIS-2,"Measurements were physical (VO2max, sit-to-stand test, MSWS-12, Spatial Recall Test, FSMC, MSIS-29, and pallidum volume. VO2max improved by 1.5 mL/kg/min, MSWS-12 by 4, FSMC by 11, and MSIS-29 by 14 points. The Spatial Recall Test improved by more than 10%.",fulltext," were found for VO 2max , sit-to-stand test, MSWS-12, Spatial Recall Test, FSMC, MSIS-29, and pallidum volume. VO 2max improved by 1.5 mL/kg/min, MSWS-12 by 4, FSMC by 11, and MSIS-29 by 14 points. The Spatial Recall Test improved by more than 10%.",92.21789883268482
669,PRECIS-2,"The EXP group received individualized training instructions during 12 weeks (3×/week), to be performed in their community aiming to participate in a training event.",fulltext,"The EXP group received individualized training instructions during 12 weeks (3×/week), to be performed in their community aiming to participate in a running event.",98.17073170731707
670,PRECIS-2,"The MSSE survey was originally developed and validated by Schwartz et al. (1996), based on the work of Lorig et al. (1989), who created a similar tool for use with people suffering from arthritis.",fulltext,"The MSSE survey was originally developed and validated by Schwartz et al. (1996), based on the work of Lorig et al. (1989), who created a similar tool for use with people suffering from arthritis.",100.0
670,PRECIS-2,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups. Inferential comparison of scores was conducted using independent t-tests at five measurement points: baseline, mid-intervention, post-intervention, mid follow up and final follow up.",fulltext,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups. Inferential comparison of scores was conducted using independent t-tests at five measurement points: baseline, mid-intervention, postintervention, mid follow up and final follow up.",99.7005988023952
670,PRECIS-2,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.",fulltext,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.",100.0
670,PRECIS-2,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.",fulltext,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.",100.0
670,PRECIS-2,"The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey. For both treatment and control groups, self efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",fulltext,"The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey. For both treatment and control groups, self-efficacy scores were obtained before the first treatment, midtreatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",99.74489795918367
670,PRECIS-2,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.",fulltext,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.",100.0
670,PRECIS-2,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.",fulltext,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.",100.0
670,PRECIS-2,"The decision as to the length of the treatment series was pragmatic and related to the length of the students' specialty clinic rotations, which are scheduled over an eight week period.",fulltext,"The decision as to the length of the treatment series was pragmatic and related to the length of the students' specialty clinic rotations, which are scheduled over an eight week period.",100.0
671,PRECIS-2,"Participants were recruited through eight health-care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",fulltext,"Participants were recruited through eight health-care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",100.0
671,PRECIS-2,Full inclusion and exclusion criteria are reported in the protocol paper.,fulltext,Full inclusion and exclusion criteria are reported in the protocol paper.,100.0
671,PRECIS-2,"The primary clinical outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score at week 36, analysed in the modified intention-to-treat population (excluding only patients who were deemed ineligible after randomisation, those who did not provide baseline and week 36 measurements).",fulltext,"The primary clinical outcome was motor function measured by the Amended Motor Club Assessment (AMCA) score at week 36, analysed in the modified intention-to-treat population (excluding only patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements).",99.03536977491962
671,PRECIS-2,"Participants were asked to stand for 30 min, three times per week over 20 weeks, and to record their standing in a diary.",fulltext,"participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",95.86776859504133
671,PRECIS-2,"An economic assessment established the resources required to provide the standing frame programme, estimated intervention costs, and estimate cost effectiveness.",fulltext,"An economic assessment established the resources required to provide the standing frame programme, estimated intervention costs, and estimate cost effectiveness.",100.0
671,PRECIS-2,"The modified intention-to-treat analysis adjusted for baseline AMCA score, region and baseline EDSS score.",fulltext,"*Adjusted for baseline AMCA Score, region and Expanded Disability Status Sc",52.83018867924528
671,PRECIS-2,"Participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary. This allowed for a graduated introduction to standing. At the end of the 20-week period, participants were encouraged to continue to regularly stand, although no further physiotherapy support was provided.",fulltext,"participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary. This allowed for a graduated introduction to standing. At the end of the 20 week period, participants were encouraged to continue to regularly stand, although no further physiotherapy support was provided.",100.0
671,PRECIS-2,"The primary clinical outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score at week 36, analysed in the modified intention-to-treat population",fulltext,"The primary clinical outcome was motor function measured by the Amended Motor Club Assessment (AMCA) score at week 36, analysed in the modified intention-to-treat population",98.29545454545455
671,PRECIS-2,The primary analysis was done in the modified intention-to-treat population and analysed.,fulltext,d in the modified intention-to-treat population and analysed ,68.53932584269663
671,PRECIS-2,"Physiotherapists (not masked to allocation) visited participants twice at home, to set up the standing frame and provide training.",fulltext,"physiotherapy support was provided. On trial completion, participants were able to keep the frame, providing ",60.0
671,PRECIS-2,"Key inclusion criteria were age older than 18 years, a diagnosis of progressive multiple sclerosis, and Expanded Disability Status Scale (EDSS) score of 6·5–8·0",fulltext,"Key inclusion criteria were age older than 18 years, a diagnosis of pro gressive multiple sclerosis (primary or secondary) accord ing to McDonald’s criteria, 21 and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",90.0
671,PRECIS-2,Participants were encouraged to continue standing after the trial and were unwilling for their standing frame to be removed.,fulltext,"participants were encouraged to continue to regularly stand, although no further physiotherapy support was provided. On trial completion, participants were able to keep the frame, providing they used it at least once per week. The use of standing frame",78.2258064516129
671,PRECIS-2,Individuals were invited consecutively until the allocated number of standing frames (dependent on availability) had been reached.,fulltext,Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health care organisation had been reached.,94.61538461538461
673,PRECIS-2,"The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights. The exercises were to sit to stand/squat, bridging, resisted shoulder flexion, walking/cycling, resisted elbow flexion, lunges or resisted knee extension, hip extension and calf raises; working to an intensity whereby the aim was to be failing on the 12th repetition of the exercise, with the load increased by 2–5%, when 12 repetitions were achieved with ease.",fulltext,"The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights. The exercises were to sit to stand/squat, bridging, resisted shoulder flexion, walking/cycling, resisted elbow flexion, lunges or resisted knee extension, hip extension and calf raises; working to an intensity whereby the aim was to be failing on the 12th repetition of the exercise, with the load increased by 2–5%, when 12 repetitions were achieved with ease.",100.0
673,PRECIS-2,"Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist. Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",fulltext,"Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist. Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",100.0
673,PRECIS-2,"The primary outcome measure was the physiological component of the Multiple Sclerosis Impact Scale-29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS. It consists of 20 questions and it is scored from 0–100, with the higher scores indicating a greater impact of MS.",fulltext,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS. It consists of 20 questions and it is scored from 0–100, with the higher scores indicating a greater impact of MS.",98.10126582278481
673,PRECIS-2,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres. Participants were randomised to a physiotherapist (PT)-led class, fitness instructor (FI)-led class, yoga class (Y) or to the control group (CG). The CG was asked not to change their exercise habit for the 10-week period between assessments.",fulltext,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres. Participants were randomised to a physiotherapist (PT)-led class, fitness instructor (FI)-led class, yoga class (Y) or to the control group (CG). The CG was asked not to change their exercise habit for the 10-week period between assessments.",100.0
673,PRECIS-2,"The yoga intervention was also not predefined, and detailed descriptions of the classes were gathered by nine of the instructors. Seven out of the nine instructors who returned details on the intervention commenced the class with breathing exercises, relaxation or 'body centering.'",fulltext,"The yoga intervention was also not predefined, and detailed descriptions of the classes were gathered by nine of the instructors. Seven out of the nine instructors who returned details on the intervention commenced the class 784 Multiple Sclerosis Journal 19(6) with breathing exercises, relaxation or ‘body centering.’",100.0
673,PRECIS-2,"They were delivered in community centres such as local gyms, hotels and health centres.",fulltext,"They were delivered in community centres such as local gyms, hotels and health centres.",100.0
673,PRECIS-2,"All three exercise groups (PT-led (n = 67), FI-led (n = 67) and yoga (n = 63)) were combined into one 'exercise' group for the MSIS-29 psychological component and both the MFIS total and physical subscales, which were greater than the control (p < 0.05). Only the PT-led and FI-led interventions significantly improved the MSIS-29 physical and 6MWT to levels greater than the control (p < 0.05).",fulltext," the MSIS-29 psychological component and both the MFIS total and physical subscales, which were greater than the control (p < 0.05). Only the PT-led and FI-led interventions significantly improved the MSIS-29 physical and 6MWT to levels greater than the control (p < 0.05).",69.11392405063292
673,PRECIS-2,"Once consent for eight people of a strand in a specific geographical area was obtained, the regional office of MSI contacted the participants to arrange a time and venue for the first assessment.",fulltext,"Once consent for eight people of a strand in a specific geographical area was obtained, the regional office of MSI contacted the national coordinator (AL) who allocated that block of participants to ",79.48717948717949
673,PRECIS-2,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical. As all groups were not treated similarly between weeks 12 and 24, and due to the high attrition rates at weeks 12 and 24, the results of our follow-up phase will be presented in a separate paper.",fulltext,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical. As all groups were not treated similarly between weeks 12 and 24, and due to the high attrition rates at weeks 12 and 24, the results of our follow-up phase will be presented in a separate paper.",100.0
674,PRECIS-2,"Kaplan-Meier estimates of risk for 6-month CDI with stratification by baseline Expanded Disability Status Scale (EDSS). Only patients with baseline EDSS ≥2.0 were included in the analysis of CDI; 154 (alemtuzumab, n = 105; subcutaneous interferon-β-1a [SC IFN-β-1a], n = 49) patients were excluded from the analysis for not meeting this criterion.",fulltext," Kaplan-Meier estimates of risk for 6-month CDI with stratification by baseline Expanded Disability Status Scale (EDSS). Only patients with baseline EDSS $2.0 were included in the analyses of CDI; 154 (alemtuzumab, n 5 105; subcutaneous interferon-b-1a [SC IFN-b-1a], n 5 49) patients were excluded from the analysis for not meeting this criterion",98.27089337175792
674,PRECIS-2,"Raters administered the MSFC18 3 times before baseline to attenuate practice effects, then every 6 months. MSFC is a multidimensional instrument comprising quantitative tests of neurologic performance in 3 critical domains: upper limb coordination and dexterity (9-Hole Peg Test [9-HPT], raw score measured in seconds); ambulation (25-Foot Timed Walking test, raw score measured in seconds); and cognition (Paced Auditory Serial Addition Test [PASAT]–3, raw score measured as number of correct responses).",fulltext," Raters administered the MSFC 16 3 times before baseline to attenuate practice effects, then every 6 months. MSFC is a multidimensional instrument comprising quantitative tests of neurologic performance in 3 critical domains: upper limb coordination and dexterity (9-Hole Peg Test [9-HPT], raw score measured in seconds); ambulation (25-Foot Timed Walking test, raw score measured in seconds); and cognitive function (Paced Auditory Serial Addition Test [PASAT]–3, raw score measured as number of correct responses)",99.60396039603961
674,PRECIS-2,"Alemtuzumab patients demonstrated 6-month confirmed disability improvement. The likelihood of achieving 6-month CDI was greater for alemtuzumab than SC IFN-β-1a (OR [95% confidence interval] 1.80 [1.06, 3.08]; p = 0.0300).",fulltext,alemtuzumab patients demonstrated 6-month confirmed disability improvement. The likelihood of improved vs stable/worsening MSFC scores was greater with alemtuzumab than SC IFN-,63.96396396396396
674,PRECIS-2,"In the phase 2 trial of alemtuzumab for RRMS (CAMMS223; NCT00050778) and the phase 3 Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis II (CARE-MS II; NCT00548405) trial, CDI was more likely in alemtuzumab-treated patients than those receiving subcutaneous interferon-β-1a (SC IFN-β-1a).",fulltext," In the phase 2 trial of alemtuzumab for RRMS (CAMMS223; NCT00050778) and the phase 3 Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis II (CARE-MS II; NCT00548405) trial, CDI was more likely in alemtuzumab-treated patients than those receiving subcutaneous interferon-b-1a (SC IFN",97.36842105263158
674,PRECIS-2,"Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II, a 2-year, randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial of alemtuzumab 12 mg with subcutaneous interferon-β-1a (SC IFN-β-1a) 44 μg in patients with RRMS.",fulltext,"Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-b-1a (SC IFN-b-1a) 44 mg in patients with RRMS.",98.47328244274809
674,PRECIS-2,"Differences in study drug administration and unique adverse event profiles precluded effective double-blinding. Blinded raters performed EDSS assessments at baseline, every 3 months, and at relapse; EDSS score changes of ≥1 point, confirmed over 3 or 6 months or longer, are accepted as clinically meaningful.",fulltext," Differences in study drug administration and unique adverse event profiles precluded effective double-blinding. Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected. EDSS score changes of $1 point, confirmed over 3 or 6 months or longer, are accepted as clinically meaningful",99.02912621359224
674,PRECIS-2,CDI is a metric reflecting durable and clinically meaningful EDSS score changes.,fulltext, CDI is a metric reflecting durable and clinically meaningful EDSS score changes,98.75
674,PRECIS-2,Alemtuzumab-treated patients were more likely than SC IFN-β-1a–treated patients to show improvement in EDSS scores (p < 0.0001) on all 7 functional systems.,fulltext,"Alemtuzumab-treated patients were more likely than SC IFN-b-1a–treated patients to show improvement in EDSS scores (p , 0.0001) on all 7 functional systems.",99.35897435897436
674,PRECIS-2,"Prespecified and post hoc disability outcomes based on Expanded Disability Status Scale (EDSS), Multiple Sclerosis Functional Composite (MSFC), and Sloan low-contrast letter acuity (SLCLA) are reported, focusing on improvement of preexisting disability in addition to slowing of disability accumulation.",fulltext,"Prespecified and post hoc disability outcomes based on Expanded Disability Status Scale (EDSS), Multiple Sclerosis Functional Composite (MSFC), and Sloan lowcontrast letter acuity (SLCLA) are reported, focusing on improvement of preexisting disability in addition to slowing of disability accumulation.",99.66996699669967
675,PRECIS-2,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",fulltext,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",100.0
675,PRECIS-2,A total of 150 patients were randomly assigned to the intervention (n = 76) or to UC (n = 74).,fulltext,A total of 150 patients were randomly assigned to the intervention (n = 76) or to UC (n = 74).,100.0
675,PRECIS-2,Intention-to-treat analyses are reported.,fulltext,Intention-to-treat analyses are reported.,100.0
675,PRECIS-2,"Assessments were made at baseline, postintervention, and 6 months follow-up.",fulltext,"Assessments were made at baseline, postintervention, and 6 months follow-up.",100.0
675,PRECIS-2,Excluded from analysis (n=0),fulltext,cluded as covariate in all analyses. B,64.28571428571428
675,PRECIS-2,Analyzed (n=76) Intention-to-treat,fulltext,Analysis. Intention-to-treat,73.52941176470588
675,PRECIS-2,"We examined effects of a mindfulness-based intervention (MBI) compared to usual care (UC) upon HRQOL, depression, and fatigue among adults with relapsing-remitting or secondary progressive MS.",fulltext,"We examined effects of a mindfulness-based intervention (MBI) compared to usual care (UC) upon HRQOL, depression, and fatigue among adults with relapsing-remitting or secondary progressive MS.",100.0
675,PRECIS-2,Homework assignments (approximately 40 minutes/day); emphasized as essential to success of the program,fulltext,"homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program",100.0
675,PRECIS-2,MBI consisted of a structured 8-week program of mindfulness training.,fulltext,MBI consisted of a structured 8-week program of mindfulness training.,100.0
675,PRECIS-2,"MBI closely followed the program of mindfulness-based stress reduction and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercises did not exceed patients' level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day); emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",fulltext,"MBI closely followed the program of mindfulness-based stress reduction 23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10 –15 participants/group; exercises did not exceed patients’ level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",100.0
677,PRECIS-2,"Eighty-one patients with chronic stroke, traumatic brain injury (TBI) and multiple sclerosis (MS) were recruited; 50 out of 81 received one month of H-CAD intervention, with one training session a day lasting 30 minutes for 5 days a week.",fulltext,"eighty-one patients with chronic stroke, traumatic brain injury (tBI) and multiple sclerosis (MS) were recruited; 50 out of 81 received 1 month of H-caD intervention, with one training session a day lasting 30 minutes for 5 days a week.",98.73949579831933
677,PRECIS-2,"The tele-rehabilitation service is mainly addressed to neurological patients after traumatic brain injury (TBI), stroke or multiple sclerosis (MS).",fulltext,"the tele-rehabilitation service is mainly addressed to neurological patients affected by traumatic brain injury (tBI), stroke or multiple sclerosis (MS).",99.31972789115646
677,PRECIS-2,"The hypothesis is that the H-CAD system is at least as effective as the usual care for arm/hand function, measured with outcome measures for arm/hand function, given to the stroke, TBI and MS patients when they are living at home.",fulltext,"the hypothesis is that the H-caD system is at least as effective as the usual care for arm/hand function, measured with outcome measures for arm/hand function, given to the stroke, tBI and MS patients when they are living at home.",100.0
677,PRECIS-2,The H-CAD parameters received from H-CAD system during the month of intervention were analyzed to detect a possible improvement in executing the exercises.,fulltext,the H-CAD parameters received from H-caD system during the month of intervention were analyzed to detect a possible improvement in the time of executing the exercises.,100.0
677,PRECIS-2,The Action Research Arm (ARA) and the Nine Hole Peg Test (NHPT) were used as main outcome measures. They proved the H-CAD system to be at least as effective as usual care.,fulltext,The Action Research Arm (ARA) and the Nine Hole Peg Test (NHPT) were used as main outcome measures. They proved the H-CAD system to be at least as effective as usual care.,100.0
677,PRECIS-2,"The H-CAD parameters received from H-CAD system during the month of intervention were analyzed and a possible improvement in execution the exercises. The analyzed exercises were book, pencil, keyboard, jar, checkers, and light bulb.",fulltext,"the H-CAD parameters received from H-caD system during the month of intervention were analyzed to detect a possible improvement in the time of executing the exercises. the analyzed exercises were book, pencil, keyboard, jar, checkers, and light bulb.",98.70689655172413
677,PRECIS-2,The ARA test was chosen as the main outcome measure because all the patients were able to perform the total test compared to the WMFT test where the patient has to stand up for some exercises - impossible for major visual problems.,fulltext,the ara test was chosen as the main outcome measure because all the patients were able to perform the total test compared to the WMFt test where the patient has to stand up for some exercises - impossible for ,90.47619047619048
677,PRECIS-2,"Patients were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UORIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSC, Belgium).",fulltext,"Patients were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UORIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSC, Belgium).",100.0
677,PRECIS-2,"For this reason, in the following of the present paper it will be named ",fulltext,"For this reason, in the following of the present paper it will be named ",100.0
677,PRECIS-2,"A total of 16 stroke patients were included in the study, 30 TBI patients and 35 MS patients. The average time since the start of the diagnosis was 9.9 years (range 1-35 years). Information about inclusion rate and number of patient data available at each measurement moment is presented in Figure 1.",fulltext,"a total of 16 stroke patients were included in the study, 30 tBI patients and 35 MS patients. the average time since the start of the diagnosis was 9.9 years (range 1-35 years). Information about inclusion rate and number of patient data available at each measurement moment is presented in Figure 1.",100.0
677,PRECIS-2, system. The instrumented desk allows the execution and monitoring of a configurable set of home exercises the professionals may purposely design to improve the main arm functions.,fulltext, system. the instrumented desk allows the execution and monitoring of a configurable set of home exercises the professionals may purposely design to improve the main arm functions.,100.0
677,PRECIS-2,The H-CAD system maintained the same functional ability in the group of patients who underwent the intervention of the H-CAD system compared to usual care.,fulltext,the HcaD system maintained the same functional ability in the group of patients who underwent the intervention of the H-caD system compared to usual care ,99.35483870967742
678,PRECIS-2,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT. We tested the differences between the two arms (expressed as differences between follow-up and baseline interviews) using one-way analysis of variance (ANOVA), checking statistical assumptions and adjusting for baseline scores. Our primary point of analysis was at 12 weeks (before the control group received the PCT).",fulltext,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT. We tested the differences between the two arms (expressed as differences between follow-up and baseline interviews) using one-way analysis of variance (ANOVA), checking statistical assumptions and adjusting for baseline scores. Our primary point of analysis was at 12 weeks (before the control group received the PCT).",100.0
678,PRECIS-2,"Subjects were 69 people with MS, 52 of whom took part in the trial (Fig. 1). Inclusion criteria were patients in South East London, living with MS and deemed by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",fulltext,"Subjects were 69 people with MS, 52 of whom took part in the trial (Fig. 1). Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",100.0
678,PRECIS-2,"Much of the work was in patients' homes, with some specialist contact in hospital being reported. Interestingly, contrary to initial concerns, input from MS nurses was not lower in the fast-track group—in fact there was a nonsignificant trend for it to be higher.",fulltext,"Much of the work was in patients’ homes, with some specialist contact in hospital being reported. Interestingly, contrary to initial concerns, input from MS nurses was not lower in the fast-track groupdin fact there was a nonsignificant trend for it to be higher.",99.61977186311786
678,PRECIS-2,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS-8), comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0–4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers' burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).",fulltext,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS8), 24,25 comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0e4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers’ burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).",99.41348973607037
678,PRECIS-2,"We conducted face-to-face interviews with patients and caregivers. At baseline, we collected demographic and clinical data, and the patient's functional status (using the Expanded Disability Status Scale [EDSS]) and interviewer-assessed using the Expanded Disability Status Scale [EDSS], administered by a consultant neurologist (E. S.)). We collected outcome and cost data at baseline (before randomization) and at 6, 12, 18 (only control group—after they received PCT), and 24 weeks.",fulltext,"We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers. At baseline, we collected demographic and clinical data, and the patient’s functional status (both self-report, using the United Kingdom Neurological Disability Scale [UNDS] 22 and interviewer-assessed using the Expanded Disability Status Scale [EDSS], 23 administered by a consultant neurologist [E. S.]). We collected outcome and cost data at baseline (before randomization) and at 6, 12, 18 (only control groupdafter they received PCT), and 24 weeks.",97.11340206185567
678,PRECIS-2,"Subjects were 69 people with MS, 52 of whom took part in the trial (Fig. 1)",fulltext,"Subjects were 69 people with MS, 52 of whom took part in the trial (Fig. 1)",100.0
678,PRECIS-2,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,fulltext,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,100.0
678,PRECIS-2," Patients were randomized to receive either the PCT immediately (fast track) or usual best practice alone (control) for 12 weeks, after which they were offered the service.",fulltext," Patients were randomized to receive either the PCT immediately (fast track) or usual best practice alone (control) for 12 weeks, after which they were offered the service.",100.0
678,PRECIS-2,"Patients in South East London who were severely affected by MS were referred by clinicians to the trial. After baseline interview, patients were randomly allocated to either a multiprofessional palliative care team (PCT) immediately (fast track) or the control care group who continued best usual care for three months and then were offered the PCT.",fulltext,"Patients in South East London who were severely affected by MS were referred by clinicians to the trial. After baseline interview, patients were randomly allocated to either a multiprofessional palliative care team (PCT) immediately (fast track) or the control care group who continued best usual care for three months and then were offered the PCT.",100.0
678,PRECIS-2,"After initial assessment, treatment was recommended.",fulltext,"After initial assessment, treatment was recommended.",100.0
679,PRECIS-2,"Assessments were at baseline and at one, three and six months.",fulltext,"Assessments were at baseline and at one, three and six months.",100.0
679,PRECIS-2,"CDT is a social cognitive theory-based intervention aiming to uncover and promote existing capabilities, with the notion 'stressor' as central concept [9]. CDT is based on the identification and reduction of stressors, client-centred group sessions and the use of another significant informal caregiver group sessions; and self-reliance, autonomy and acceptance as central themes [9]. CDT focuses on the exploration of those stressors that confine patients to their physical, psychological or social roles regarding their disease and limitations; reduces relevant stressors; explores and pushes personal boundaries by making optimal use of the existing potential [9].",fulltext,"CDT is a social cognitive theory-based intervention aiming to uncover and promote existing capabilities, with the notion ‘stressor’ as central concept [9]. CDT is based on the identification and reduction of stressors; client-centeredness; potential inclusion of partner or another significant informal caregiver; group sessions; and self-reliance, autonomy and acceptance as central themes [9]. CDT focuses on the exploration of those stressors that confine patients to their physical, psychological or social roles regarding their disease and limitations; reduces relevant stressors; explores and pushes personal boundaries; and creates new personal boundaries by making optimal use of the existing potential [9].",97.4512743628186
679,PRECIS-2,"Follow-up assessments were at one, three and six months. Primary endpoint was control self-efficacy (Multiple Sclerosis Self-Efficacy Scale Control [MSSES-C] (minimum 90, maximum 900) at six months.",fulltext,"Follow-up assessments were at one, three and six months. Primary endpoint was control self-efficacy (Multiple Sclerosis Self-Efficacy Scale Control [MSSES-C] (minimum 90, maximum 900) at six months.",100.0
679,PRECIS-2,"Multiple regression analysis with age, gender, disease duration, EDSS score and education as independent variables and MSSES-C at six months as a dependent variable showed no associations. At six months, 31 of 54 (57.4%) CDT patients and 26 of 56 (46.4%) control patients had an improved control self-efficacy, whereby improvement was defined as an increase of at least 75 points compared to baseline, being ≥0.5 SD baseline (n = 155).",fulltext," Multiple regression analysis with age, gender, disease duration, EDSS score and education as independent variables and MSSES-C at six months as a dependent variable showed no associations. At six months, 31 of 54 (57.4%) CDT patients and 26 of 56 (46.4%) control patients had an improved control self-efficacy, whereby improvement was defined as an increase of at least Effect of social cognitive treatment on control self-efficacy in multiple sclerosis PLOS ONE | https://doi.org/10.1371/journal.pone.0223482 October 10, 2019 7 / 14 75 points compared to baseline, being �0.5 SD baseline (n = 155)",99.77011494252874
679,PRECIS-2,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet.",fulltext,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet.",100.0
679,PRECIS-2,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands. Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.",fulltext,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands. Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.",100.0
679,PRECIS-2,"The baseline and follow-up values for the primary, secondary and tertiary outcomes in both groups, and the between-group differences at follow-up are presented in Table 2. At six months the MSSES-C score did not statistically significantly differ between the two groups.",fulltext,"The baseline and follow-up values for the primary, secondary and tertiary outcomes in both groups, and the between-group differences at follow-up are presented in Table 2. At six months the MSSES-C score did not statistically significantly differ between the two groups.",100.0
679,PRECIS-2,"The person with MS had experience with chronic symptoms and multiple disease-modifying treatments. As the team members were also involved in the preceding observational study—except for the dance therapist-, the team was experienced in providing CDT [9].",fulltext,"The person with MS had experience with chronic symptoms and multiple disease-modifying treatments. As the team members were also involved in the preceding observational study—except for the dance therapist -, the team was experienced in providing CDT [9].",100.0
679,PRECIS-2,The study population was low-disability RRMS patients with or without support partner.,fulltext,The study population was low-disability RRMS patients with or without support partner.,100.0
679,PRECIS-2,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months [12]. The MSSES is a specific and sensitive self-report questionnaire consisting of two 9-items subscales for control and functional self-efficacy, with a high internal consistency and test-retest reliability [12].",fulltext,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months [12]. The MSSES is a specific and sensitive self-report questionnaire consisting of two 9-items subscales for control and functional self-efficacy, with a high internal consistency and test-retest reliability [12].",100.0
679,PRECIS-2,"We did a single-centre, randomized (1:1), unmasked, parallel-group, controlled trial in the Netherlands.",fulltext,"We did a single-centre, randomized (1:1), unmasked, parallel-group, controlled trial in the Netherlands.",100.0
679,PRECIS-2,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS [9]. All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS.",fulltext,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS [9]. All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS.",100.0
680,PRECIS-2,"Effect sizes from pre to post and pre to follow up were calculated using Cohen's d for each outcome measure. All statistical analyses included a sample of 30 participants at pre, post and 20 weeks follow up and were undertaken controlling for gender and ambulation status.",fulltext,"ovariate. Effect sizes from pre to post and pre to follow up were calculated using Cohen’s d for each outcome measure. All statistical analyses included a sample of 30 participants at pre, post and 20 weeks follow up and were undertaken controlling for gender and ambulati",96.32352941176471
680,PRECIS-2,"Follow up assessments ended April, 2015. The trial was stopped after achieving a total number of 30 participants (15 in each group).",fulltext,"Follow up assessments ended April, 2015. The trial was stopped after achieving a total number of 30 participants (15 in each group).",100.0
680,PRECIS-2,"The study took place at a large teaching and research hospital in Melbourne, Australia.",fulltext,"The study took place at a large teaching and research hospital in Melbourne, Australia.",100.0
680,PRECIS-2,"The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies. These strategies included progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs.",fulltext,"The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies. These strategies included progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs.",100.0
680,PRECIS-2,"The study took place at a large teaching and research hospital in Melbourne, Australia. Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",fulltext,"The study took place at a large teaching and research hospital in Melbourne, Australia. Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",100.0
680,PRECIS-2,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,fulltext,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,100.0
680,PRECIS-2,Clinicians who delivered the intervention were also involved in providing the assessment questionnaires to participants.,fulltext,Clinicians who delivered the intervention were also involved in providing the assessment questionnaires to participants.,100.0
680,PRECIS-2,"The aim of the 8-week tailored intervention is to significantly decrease level of depressive symptoms (primary outcome), anxiety, fatigue and pain impact and to contribute to improvements in levels of quality of life, sleep difficulties, MS illness acceptance, active coping skills, social support and resilience (secondary outcomes) in those newly diagnosed with MS.",fulltext,"The aim of the 8-week tailored intervention is to significantly decrease level of depressive symptoms (primary outcome), anxiety, fatigue and pain impact and to contribute to improvements in levels of quality of life, sleep difficulties, MS illness acceptance, active coping skills, social support and resilience (secondary outcomes) in those newly diagnosed with MS.",100.0
680,PRECIS-2,"One female senior clinical psychologist and one male provisional clinical psychologist undertook assessments. During this baseline interview, the goals and procedures were explained in detail and written consent was obtained from all participants.",fulltext,"One female senior clinical psychologist and one male provisional clinical psychologist undertook assessments. During this baseline interview, the goals and procedures were explained in detail and written consent was obtained from all participants.",100.0
680,PRECIS-2,The primary outcome was level of depressive symptoms at post and 20 weeks follow up which was measured with the Beck Depression Inventory-II (BDI-II) [26].,fulltext,The primary outcome was level of depressive symptoms at post and 3 month follow up which was measured with the Beck Depression Inventory-II (BDI-II) [26].,95.48387096774194
681,PRECIS-2,"The recruitment and retention of participants missing classes due to other appointments, family/work commitments, transport problems, holidays or mild ill-health (e.g. common cold).",fulltext," participants missing classes due to other appointments, family/work commitments, transport problems, holidays or mild ill-health (e.g. common cold).",82.32044198895028
681,PRECIS-2,Attendance of participants at each class was recorded.,fulltext,Attendance of participants at each class was recorded.,100.0
681,PRECIS-2,"Outcome measures were carried out within the local hospital's rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",fulltext,"Outcome measures were carried out within the local hospital's rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",100.0
681,PRECIS-2,"For the primary outcome measure, the Timed 25-Foot Walk Test, the ANOVA results demonstrated no statistically significant difference over time (Table 2). Although there was no statistically significant improvement in the Timed 25-Foot Walk Test, the mean scores improved by 7.2 seconds (24%) in the intervention group compared with the 3 seconds (19%) in the control group.",fulltext,"For the primary outcome measure, the Timed 25-Foot Walk Test, the ANOVA results demonstrated no statistically significant difference over time (Table 2). Although there was no statistically significant improvement in the Timed 25-Foot Walk Test the mean scores improved by 7.2 seconds (24%) in the intervention group compared with the 3 seconds (19%) in the control group.",99.73190348525469
681,PRECIS-2,Two community leisure centres.,fulltext,Two community leisure centres.,100.0
681,PRECIS-2,"On initial inspection our attendance rates (71%) appear lower than other studies with similar class-based methodology16,21,26,28 all of whom reported greater than 80% attendance.",fulltext,"On initial inspection our attendance rates (71%) appear lower than other studies with similar classbased methodology 16,21,26,28 all of whom reported greater than 80% attendance.",99.43820224719101
681,PRECIS-2,"The Timed 25-Foot Walk Test35 was chosen as the primary outcome measure. The Timed 25-Foot Walk Test measures walking speed over a short distance and has shown good reliability and validity in the multiple sclerosis population as an individual component of the Multiple Sclerosis Functional Composite disability assessment.36,37",fulltext,"The Timed 25-Foot Walk Test 35 was chosen as the primary outcome measure. The Timed 25Foot Walk Test measures walking speed over a short distance and has shown good reliability and validity in the multiple sclerosis population as an individual component of the Multiple Sclerosis Functional Composite disability assessment. 36,",99.08536585365853
681,PRECIS-2,"The intervention group received 12 weeks of twice weekly, 60-minute group exercise sessions, including mobility, balance and resistance exercises. The control group received usual care.",fulltext,"The intervention group received 12 weeks of twice weekly, 60-minute group exercise sessions, including mobility, balance and resistance exercises. The control group received usual care.",100.0
681,PRECIS-2,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets. Forty-three potential participants expressed an interest in participating.,fulltext,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets. Forty-three potential participants expressed an interest in participating.,100.0
681,PRECIS-2,"Participants assigned to the intervention group attended a leisure centre-based exercise class, twice weekly for 12 weeks. Each group was led by two instructors (one physiotherapist and one fitness instructor). The same physiotherapist was present at both sites; however fitness instructors were different between sites.",fulltext,"Participants assigned to the intervention group attended a leisure centre-based exercise class, twice weekly for 12 weeks. Each group was led by two instructors (one physiotherapist and one fitness instructor). The same physiotherapist was present at both sites; however fitness instructors were different between sites.",100.0
681,PRECIS-2,Thirty-two participants with multiple sclerosis randomized into intervention or control groups.,fulltext,Thirty-two participants with multiple sclerosis randomized into intervention or control groups.,100.0
681,PRECIS-2,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",fulltext,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",100.0
682,PRECIS-2,"On Push Days, participants were instructed to do short bursts of moderate-high intensity exercise to their own tolerance (e.g. for 1–3 minutes) and then reduce to a more comfortable pace for 5–7 minutes and repeat as they are possible. Supplementary Material Tables 4S and 5S present the specifics of the MSTEP© programme.",fulltext,"On Push Days, participants were instructed to do short bursts of moderate-high intensity exercise to their own tolerance (e.g. for 1–3 minutes) and then reduce to a more comfortable pace for 5–7 minutes and repeat as they are possible. Supplementary Material Tables 4S and 5S present the specifics of the MSTEP© programme.",100.0
682,PRECIS-2,The intention was to follow participants for the first year of the intervention when the exercise programme was designed and adjusted as needed and have a further follow-up after the second year.,fulltext,The intention was to follow participants for the first year of the intervention when the exercise programme was designed and adjusted as needed ,73.84615384615385
682,PRECIS-2,"People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites. During the clinic visit, the treating neurologist introduced the study to their patients and referred them to the research assistant who further explained the study and assessed eligibility.",fulltext,"People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites. During the clinic visit, the treating neurologist introduced the study to their patients and referred them to the research assistant who further explained the study and assessed eligibility.",100.0
682,PRECIS-2,The target population was community dwelling individuals aged 19 to 65 who have been diagnosed after 1994 with multiple sclerosis.,fulltext,The target population was community dwelling individuals aged 19 to 65 who have been diagnosed after 1994 with multiple sclerosis.,100.0
682,PRECIS-2,"Primary outcome was peak oxygen consumption (VO2peak) at 12 months; secondary outcomes were composite measures of physical function, fatigue, and health-related quality of life.",fulltext,"Primary outcome was peak oxygen consumption (VO 2peak ) at 12 months; secondary outcomes were composite measures of physical function, fatigue, and health-related quality of life.",100.0
682,PRECIS-2,"A mixed effects model for VO2peak (continuous variable); interaction group × time non-significant, main effects only presented. The group effect is interpreted as the difference between groups averaged over time; as the 95% CI included the null value of 0, the group effect was non-significant.",fulltext,"ote: Mixed effects model for VO 2peak (continuous variable); interaction group × time non-significant, main effects only presented. The group effect is interpreted as the difference between groups averaged over time; as the 95% CI included the null value of 0, the group effect was non-signific",98.29931972789116
682,PRECIS-2,"Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS),10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).",fulltext,"Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS), 10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).",100.0
682,PRECIS-2,"Two different types of exercise interventions were contrasted. MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement. The goal of the MSTEP© programme is to promote regular bouts of activity most days per week, encouraging a balance between rest and activity, and taking into consideration the physical and emotional status and capacity of the person.",fulltext,"Two different types of exercise interventions were contrasted. MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement. The goal of the MSTEP© programme is to promote regular bouts of activity most days per week, encouraging a balance between rest and activity, and taking into consideration the physical and emotional status and capacity of the person.",100.0
682,PRECIS-2,"All participants were contacted every two weeks during the first two months, then monthly thereafter by the exercise instructor by telephone or email for follow-up by the instructor. The purpose of follow-up contacts is to provide an opportunity to ask any questions they have and also to facilitate long-term retention in the study.",fulltext,"All participants were contacted every two weeks during the first two months, then monthly thereafter by the exercise instructor by telephone or email for follow-up by the instructor. The purpose of follow-up contacts is to provide an opportunity to ask any questions they have and also to facilitate long-term retention in the study.",100.0
684,PRECIS-2,Setting: Community; subjects' homes.,fulltext,Setting: Community; subjects' homes.,100.0
684,PRECIS-2,Primary outcome measure: Multiple Sclerosis Impact Scale (MSIS29),fulltext,Primary outcome measure: Multiple Sclerosis Impact Scale (MSIS29),100.0
684,PRECIS-2,"Each session lasted up to 60 minutes, and a task-specific programme was developed by the treating physiotherapist which was reviewed at each of the three assessments.",fulltext,"Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using thera",57.22891566265061
684,PRECIS-2,"Subjects: Thirty people moderately to severely affected by MS (Extended Disability Status Score, EDSS, 6.5–8) were randomized to an intervention or control group.",fulltext,"Subjects: Thirty people moderately to severely affected by MS (Extended Disability Status Score, EDSS, 6.5–8) were randomized to an intervention or control group.",100.0
684,PRECIS-2,"The intervention group received twice weekly, home-based physiotherapy for eight weeks and the control group received usual care.",fulltext,"The intervention group received twice weekly, home-based physiotherapy for eight weeks and the control group received usual care.",100.0
684,PRECIS-2,"The following outcome measures were recorded at baseline, post-intervention (Week 8) and at follow-up (Week 16). Primary outcome measure: Multiple Sclerosis Impact Scale (MSIS29) and secondary outcome measures assessed physical impairment, MS symptoms, quality of life, mood, and disability.",fulltext,"The following outcome measures were recorded at baseline, post-intervention (Week 8) and at follow-up (Week 16). Primary outcome measure: Multiple Sclerosis Impact Scale (MSIS29) and secondary outcome measures assessed physical impairment, MS symptoms, quality of life, mood, and disability.",100.0
684,PRECIS-2,41 potential participants responded and screened,fulltext,41 potential participants responded and screened,100.0
684,PRECIS-2,"All outcome variables were summarized and comparisons made between groups and over time. Outcome variables that could be shown to be analysed using parametric procedures (e.g. F1M), were analysed using a two-factor repeated measures ANOVA with two factors being time (0, 8 and 16) and group (1,2), thus allowing for possible interaction effects to assess whether groups react differently over time.",fulltext,"All outcome variables were summarized and comparisons made between groups and over time. Outcome variables that could be shown to be analysed using parametric procedures (e.g. FIM), were analysed using a two-factor repeated measures ANOVA with the two factors being time (0, 8 and 16) and group (1,2), thus allowing for possible interaction effects to assess whether groups react differently over time.",99.74874371859298
684,PRECIS-2,Ninety-one potential participants were identified and sent a letter of invitation,fulltext, potential participants identified and sent a letter of invitation,81.4814814814815
685,PRECIS-2,Assessments were conducted at baseline and again six months later.,fulltext,Assessments were conducted at baseline and again six months later.,100.0
685,PRECIS-2,"The disease course is very varied, but is progressive in nature in many people. Individuals with MS experience an array of symptoms and disabilities, which can place a major burden on those with MS and their families, as well as on health and social services and the economy sector.",fulltext,"The disease course is very varied, but is progressive in nature in many people. Individuals with MS experience an array of symptoms and disabilities, which can place a major burden on those with MS and their families, as well as on health and social services and the voluntary sector.",98.58156028368793
685,PRECIS-2,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",fulltext,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",100.0
685,PRECIS-2,Two hundred and seventy-eight people with MS were invited to take part in the study. One hundred and eighty-nine people consented to take part (68%).,fulltext,Two hundred and seventy-eight people with MS were invited to take part in the study. One hundred and eighty-nine people consented to take part (68%).,100.0
685,PRECIS-2,"An independent person not involved in the study randomized each participant using random number tables, with odd/even number allocation to intervention/control group, with random draw.",fulltext,"An independent person not involved in the study randomized each participant using random number tables, with odd/even number allocation to intervention/control group, with random draw.",100.0
685,PRECIS-2,Seventy-three individuals were in the intervention group and 96 were in the control group.,fulltext,Seventy-three individuals were in the intervention group and 96 were in the control group.,100.0
685,PRECIS-2,"The discussions lasted between 1 and 2 hours and were conducted on two occasions, over a one month period.",fulltext,"The discussions lasted between 1 and 2 hours and were conducted on two occasions, over a one month period.",100.0
685,PRECIS-2,"A range of physical and psychological scales was included in order to obtain a comprehensive evaluation of the intervention. Total scores on a postal version of the Barthel Index, a scale measuring mobility, the United Kingdom version of the SF-36 and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.",fulltext,"A range of physical and psychological scales was included in order to obtain a comprehensive evaluation of the intervention. Total scores on a postal version of the Barthel Index, 11 a scale measuring mobility, 12 the United Kingdom version of the SF-36 13 and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.",100.0
685,PRECIS-2,Participants were community based and lived in West London and in counties contiguous with Greater London.,fulltext,"ns, were community based and lived in West London and in counties contiguous with Greater London.",90.56603773584906
685,PRECIS-2,The study was conducted with people with MS living in the community.,fulltext,The study was conducted with people with MS living in the community.,100.0
686,PRECIS-2,MS patients from the outpatient clinic of the Neurology Department of Pitié-Salpêtrière Hospital were prospectively enrolled in the study between March to July 2012.,fulltext,ents MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July,93.33333333333333
686,PRECIS-2,"MS patients from the outpatient clinic of the Neurology Department of Pitié-Salpêtrière Hospital were prospectively enrolled in the study between March to July 2012. Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neuro-urology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist).",fulltext,"ents MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July 2012. Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neurourology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsycholo",98.03600654664486
686,PRECIS-2,Fifty MS patients were included.,fulltext,Fifty MS patients were included.,100.0
686,PRECIS-2,"For the sample size, calculations were based on a preliminary study,12 including 40 MS patients. In this pilot study a mean improvement of 10 points over six months on the MSIS-29 scale in the IMD group and a mean worsening of six points in the control group was observed. The standard deviation for the change in the MSIS-29 was 14 points. With the same hypotheses, 22 patients per group were necessary to provide the study a power of 90% with a type 1 error rate of 0.05. To take into account a possible dropout rate, we randomized 25 patients per group.",fulltext,"ical analyses For the sample size, calculations were based on a preliminary study 12 including 40 MS patients. In this pilot study a mean improvement of 10 points over six months on the MSIS-29 scale in the IMD group and a mean worsening of six points in the control group was observed. The standard deviation for the change in the MSIS-29 was 14 points. With the same hypotheses, 22 patients per group were necessary to provide the study a power of 90% with a type 1 error rate of 0.05. To take into account a possible dropout rate, we randomized 25 patie",97.48201438848922
686,PRECIS-2,"Fifty MS patients were included. Median MSIS 29 score decreased over six months in the control group (−4.89) and increased in the IMD group (+2.00), with a significant difference between the two groups (p = 0.03). However, in the multivariate analysis, after adjustment of HAD-D and INTERMED score, this difference was no longer significant.",fulltext,"Fifty MS patients were included. Median MSIS 29 score decreased over six months in the control group (4.89) and increased in the IMD group (þ2.00), with a significant difference between the two groups (p ¼ 0.03). However, in the multivariate analysis, after adjustment of HAD-D and INTERMED score, this difference was no longer significant.",99.41348973607037
686,PRECIS-2,"At the end of the visit, a summary of the multidisciplinary evaluation, along with the resulting therapeutic propositions, was discussed with the patient and caregivers. For patients in the control group, interventions with the different health professionals were planned after the inclusion visit, with an explanatory letter given to the patient or directly sent to the professionals. In most cases the same health professionals were in charge of the two groups.",fulltext,"ogist. At the end of the visit, a summary of the multidisciplinary evaluation, along with the resulting therapeutic propositions, was discussed with the patient and caregivers. For patients in the control group, interventions with the different health professionals were planned after the inclusion visit, with an explanatory letter given to the patient or directly sent to the professionals. In most cases the same health professionals were in charge of the two ",98.48812095032397
686,PRECIS-2,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,fulltext,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,100.0
687,PRECIS-2,"The website, which was used to deliver the intervention, was developed in collaboration with a patient steering group and incorporating recommendations from the MS Society accessibility policy and advice from the British Accessibility Information Forum.",fulltext,"The website, which was used to deliver the intervention, was developed in collaboration with a patient steering group and incorporating recommendations from the MS Society accessibility policy and advice from the Scottish Accessible Information Forum.",97.23320158102767
687,PRECIS-2,A randomized controlled pilot study. Setting: Rehabilitation centre and participants' homes.,fulltext,A randomized controlled pilot study. Setting: Rehabilitation centre and participants' homes.,100.0
687,PRECIS-2,"Ethical approval was received from the West of Scotland Research Ethics Service (ref: 12/WS/0147) and participants were recruited from the Multiple Sclerosis Service, at the Douglas Grant Rehabilitation Centre, Irvine, Scotland.",fulltext,"Ethical approval was received from the West of Scotland Research Ethics Service (ref: 12/ WS/0147) and participants were recruited from the Multiple Sclerosis Service, at the Douglas Grant Rehabilitation Centre, Irvine, Scotland.",100.0
687,PRECIS-2,"Outcome measures were recorded at baseline and at the end of the intervention period (week 13). The primary outcome measure, the timed 25 foot walk, has good reliability and validity in the MS population.",fulltext,"Outcome measures were recorded at baseline and at the end of the intervention period (week 13). The primary outcome measure, the timed 25 foot walk, 14 has good reliability and validity in the MS population.",100.0
687,PRECIS-2,"The primary outcome measure, the timed 25 foot walk, has good reliability and validity in the MS population.",fulltext,"The primary outcome measure, the timed 25 foot walk, 14 has good reliability and validity in the MS population.",100.0
687,PRECIS-2,Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).,fulltext,Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).,100.0
687,PRECIS-2,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",fulltext,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",100.0
687,PRECIS-2,"Participants were given unique log-in details to view their own, online personalised exercise programme. This was a pragmatic study with the content of the web-based programme being similar to the content if it had been delivered face-to-face.",fulltext,"Participants were given unique log-in details to view their own, online personalised exercise programme. This was a pragmatic study with the content of the web-based programme being similar to the content if it had been delivered face-to-face.",100.0
687,PRECIS-2,All analysis was performed on SPSS v20 with power calculations for a future fully powered trial being estimated using nQuery v7.,fulltext,All analysis was performed on SPSS v20 with power calculations for a future fully powered trial being estimated using nQuery v7.,100.0
687,PRECIS-2,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.,fulltext,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.,100.0
688,PRECIS-2,"Patients were randomised to home (intervention) or hospital care (control) in a ratio of 2:1, in order to ensure that the home care population was sufficiently represented.",fulltext,"Patients were randomised to home (intervention) or hospital care (control) in a ratio of 2:1, in order to ensure that the home care population was sufficiently represented.",100.0
688,PRECIS-2,Rome service area. Eligible patients were assessed for suitability by the coordinator of the home based care team (LP).,fulltext,Rome service area. Eligible patients were assessed for suitability by the coordinator of the home based care team (LP).,100.0
688,PRECIS-2,Ninety six patients were recruited to take part to the study because they were referred to the multiple sclerosis centres only for a second opinion but were regularly followed by their own neurologists.,fulltext,consent to take part to the study because they were referred to the multiple sclerosis centres only for a second opinion but were regularly followed by their own neurologists.,85.64356435643565
688,PRECIS-2,"Eligible patients were assessed for suitability by the coordinator of the home based care team (LP). Written informed consent was obtained for entry into the trial from the patients and, when appropriate, from their carers.",fulltext,"Eligible patients were assessed for suitability by the coordinator of the home based care team (LP). Written informed consent was obtained for entry into the trial from the patients and, when appropriate, from their carers.",100.0
688,PRECIS-2,"The costs of inpatient care (ordinary, rehabilitation, day hospital, and diagnostic tests) were estimated using Italian third party payer reimbursement for diagnosis related groups (DRGs) as a proxy for the real costs. Outpatients and community resources were calculated through the outpatient prices developed by the National Health Service.",fulltext," The costs of inpatient care (ordinary, rehabilitation, day hospital, and diagnostic tests) were estimated using Italian third party payer reimbursement for diagnosis related groups (DRGs) as a proxy for the real cost. Outpatients and community resources were calculated through the outpatient prices developed by the National Health Service",99.41520467836258
688,PRECIS-2,"For the intervention group, we estimated the costs to cover the local management and administration of the home based management scheme (for the operator, coordinator, telephone, and overheads). The costs used in the analysis were calculated on the basis of 1999 Italian prices converted to euros. The one year time horizon did not require discounting in the analysis.",fulltext," For the intervention group, we estimated the costs to cover the local management and administration of the home based management scheme (for the operator, coordinator, telephone, and overheads). The costs used in the analysis were calculated on the basis of 1999 Italian prices converted to euros. The one year time horizon did not require discounting in the analysis",99.72826086956522
688,PRECIS-2,A minority of refusers (n = 34) did not consent to take part to the study because they were referred to the multiple sclerosis centres only for a second opinion but were regularly followed by their own neurologists.,fulltext,A minority of refusers (n = 34) did not consent to take part to the study because they were referred to the multiple sclerosis centres only for a second opinion but were regularly followed by their own neurologists.,100.0
688,PRECIS-2,"Randomisation (in blocks of six) was expanded disability status score (EDSS),14 because both health outcomes and costs differ according to disease disability and age15 16 and a valid conclusion can be drawn only by comparing similar patients.",fulltext,"Randomisation (in blocks of six) was stratified by age and expanded disability status score (EDSS), 18 because both health outcomes and costs differ according to disease disability and age 5 19 and a valid conclusion can be drawn only by comparing similar patients.",98.7603305785124
689,PRECIS-2,"All analysis was performed on IBM SPSS v24, using a 5% level of significance (IBM, New York, USA).",fulltext,"All analysis was performed on IBM SPSS v24, using a 5% level of significance (IBM, New York, USA).",100.0
689,PRECIS-2,"Participants walked twice, once with their device and once without, at weeks 0, 3, 6 and 12 months; 5-minute self-selected walk test (primary).",fulltext,"Participants walked twice, once with their device and once without, ",47.55244755244755
689,PRECIS-2,The primary outcome was walking speed as measured by the 5-minute self-selected walk test.,fulltext,The primary outcome was walking speed as measured by the 5-minute self-selected walk test.,100.0
689,PRECIS-2,Eighty-five treatment-naïve people with Multiple Sclerosis with persistent (>three months) foot drop.,fulltext,Eighty-five treatment-naïve people with Multiple Sclerosis with persistent (>three months) foot drop.,100.0
689,PRECIS-2,The order of testing was randomized between participants but was kept consistent for each participant throughout the trial.,fulltext,The order of testing was randomized between participants but was kept consistent for each participant throughout the trial.,100.0
689,PRECIS-2,"Participants were screened for eligibility, and written informed consent was gained prior to randomization.",fulltext,"participants were screened for eligibility, and written informed consent was gained prior to randomization.",100.0
689,PRECIS-2,Eighty-five participants were recruited allowing for an approximate 15% attrition rate.,fulltext,Eightyfive participants were recruited allowing for an approximate 15% attrition rate.,98.85057471264368
689,PRECIS-2,A minimum of 37 participants were required to detect a change of at least 75% of 1 standard deviation value (0.16 m/s) to achieve a power of 90% at a 5% level of significance.,fulltext,A minimum of 37 participants were required to detect a change of at least 75% of 1 standard deviation value (0.16 m/s) to achieve a power of 90% at a 5% level of significance.,100.0
689,PRECIS-2,"Seven Multiple Sclerosis outpatient centres across Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet.",fulltext," Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet.",95.49180327868852
689,PRECIS-2,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,fulltext,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,100.0
689,PRECIS-2,The current amplitude ranged from 7 to 72 mA (mean = 40 mA). Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,fulltext,The current amplitude ranged from 7 to 72 mA (mean = 40 mA). Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,100.0
690,PRECIS-2,We performed a multicenter RCT involving adults with severe MS and their carers to assess the effectiveness of a home-based palliative approach (HPA) added to usual care (UC).,fulltext,We performed a multicenter RCT involving adults with severe MS and their carers to assess the effectiveness of a home-based palliative approach (HPA) added to usual care (UC).,100.0
690,PRECIS-2,"HPs. On average, dyads received 4.9 home visits in the first 3 months and 2.8 in the second 3 months. The nurse (team leader) performed 152 visits (33%), followed by the psychologist (25%), the physician (25%), and the social worker (17%).",fulltext,"r HPs. On average, dyads received 4.9 home visits in the first 3 months and 2.8 in the second 3 months. The nurse (team leader) performed 152 visits (33%), followed by the psychologist (25%), the physician (25%), and the social worker (17%",99.16317991631799
690,PRECIS-2,"Primary outcome measures were Palliative care Outcome Scale-Symptoms-MS (POS-S-MS) and Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW, not assessed in severely cognitively compromised patients).",fulltext,"Primary outcome measures were Palliative care Outcome Scale-Symptoms-MS (POS-S-MS) and Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW, not assessed in severely cognitively compromised patients).",100.0
690,PRECIS-2,50 dyads were analyzed; 2 dyads were excluded from analysis; - 2 did not receive allocated intervention,fulltext, Dyads were randomly assigned (2:1) to receive HPA or UC. Allocat,41.747572815533985
690,PRECIS-2,Adults with severe MS-carer dyads were assigned (2:1 ratio) to either HPA or usual care (UC).,fulltext,Adults with severe MS-carer dyads were assigned (2:1 ratio) to either HPA or usual care (UC).,100.0
690,PRECIS-2,"Based on the principles of PC,17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker. Nurses of the Milan and Rome centers had degrees and worked full time in PC; the Catania nurse attended a week-long individual training course.",fulltext,"Based on the principles of PC, 17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker. Nurses of the Milan and Rome centers had degrees and worked full time in PC; the Catania nurse attended a week-long individual training course.",100.0
690,PRECIS-2,"At each center, a multi-professional team delivered the 6-month intervention. A blind examiner assessed dyads at baseline, 3 months, and 6 months.",fulltext,"At each center, a multi-professional team delivered the 6-month intervention. A blind examiner assessed dyads at baseline, 3 months, and 6 months.",100.0
690,PRECIS-2,"At each center, a multi-professional team delivered the 6-month intervention.",fulltext,"At each center, a multi-professional team delivered the 6-month intervention.",100.0
690,PRECIS-2,"A blind examiner assessed dyads at baseline, 3 months, and 6 months.",fulltext,"A blind examiner assessed dyads at baseline, 3 months, and 6 months.",100.0
690,PRECIS-2,0 dyads were lost to follow-up; 4 dyads discontinued intervention; - 3 patients died (one after 12-week visit); - 1 withdrew consent (before 12-week visit); 1 dyad did not perform visit 3,fulltext,"ee dyads discontinued the intervention, one in the HPA group and two in the UC group (Figure 1); one HPA dyad completed the intervention but did not perform visit",50.80213903743316
690,PRECIS-2,"Mean change in POS-S-MS score from baseline to 3 months was 1.1 (95% confidence interval (CI), −0.5 to 2.7) in the HPA group and −0.2 (95% CI, −2.9 to 2.6) in the UC group, with a mean between-group difference of 1.3 (95% CI, −1.7 to 4.2), and a Cohen's d effect size (ES) of 0.20.",fulltext,"Mean change in POS-S-MS score from baseline to 3 months was 1.1 (95% confidence interval (CI), −0.5 to 2.7) in the HPA group and −0.2 (95% CI, −2.9 to 2.6) in the UC group, with a mean between-group difference of 1.3 (95% CI, −1.7 to 4.2), and a Cohen's d effect size (ES) of 0.20.",100.0
691,PRECIS-2,Individuals who had attended a fatigue management programme in the past 3 months (see protocol col).,fulltext,Individuals who had attended a fatigue management programme in the past ,72.0
691,PRECIS-2,Three-centre parallel arm randomised controlled trial with economic evaluation. Patients with MS and significant fatigue were randomised to FACETS or current local practice.,fulltext,Three-centre parallel arm randomised controlled trial with economic evaluation. Patients with MS and significant fatigue were randomised to FACETS plus current local practice ,98.84393063583815
691,PRECIS-2,"The aim of the intervention is to help people normalise their fatigue experiences, learn helpful ways of thinking about fatigue and use their available energy more effectively. The intervention consists of six sessions (∼90 min duration) held weekly and facilitated in groups of 6–12 by two health professionals with experience of working with people with MS and group-work (such as occupational therapists, nurses or physiotherapists).",fulltext,"The aim of the intervention is to help people normalise their fatigue experiences, learn helpful ways of thinking about fatigue and use available energy more effectively. The intervention consists of six sessions (∼90 min duration) held weekly and facilitated in groups of 6–12 by two health professionals with experience of working with people with MS and group-work (such as occupational therapists, nurses or physiotherapists).",98.62385321100918
691,PRECIS-2,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale score >4) and (3) ambulatory. The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",fulltext,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4) 16 and (3) ambulatory. The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",100.0
691,PRECIS-2,Participants randomised to the CLP arm of the trial received current local practice advice and information provision about MS-fatigue to more detailed individualised management advice from a variety of health professionals.,fulltext,Participants randomised to the CLP arm of the trial received current local practice only. This could have ranged from general advice and information provision about MS-fatigue to more detailed individualised management advice from a variety of health professionals.,100.0
691,PRECIS-2,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",fulltext,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",100.0
691,PRECIS-2,The main analysis was intention-to-treat but we also conducted a 'per protocol' analysis (excluding participants who attended fewer than four FACETS sessions).,fulltext,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,100.0
691,PRECIS-2,The primary 'intention-to-treat' analyses and results for the primary outcome measures are shown in table 2 and online supplementary figure S1. There were statistically significantly greater improvements in fatigue self-efficacy in the FACETS arm at follow-up 1 compared with the CLP arm.,fulltext, The primary ‘intention-to-treat’ analyses and results for the primary outcome measures are shown in table 2 and online supplementary figure S1. There were statistically significantly greater improvements in fatigue self-efficacy in the FACETS arm at follow-up 1 and 2 compared with the CLP arm,99.65277777777779
691,PRECIS-2,"A total of 164 people were randomised (time from primary care) (figure 1). First follow-up data are available for 146 (89%) and second follow-up for 144 (88%). Recruitment was 39 from the South West, 75 from the Southampton/Portsmouth Centre and 50 from the Poole centre. In all, 84 participants were randomised to FACETS and 80 to CLP. Overall, 10 FACETS programmes were run with group sizes ranging from 4 to 11 (mean=7.4; SD=2.1).",fulltext," A total of 164 people were randomised (nine from primary care) (figure 1). First follow-up data are available for 146 (89%) and second follow-up for 144 (88%). Recruitment was 39 from the Bristol centre, 75 from the Southampton/Portsmouth Centre and 50 from the Poole centre. In all, 84 participants were randomised to FACETS and 80 to CLP. Overall, 10 FACETS programmes were run with group sizes ranging from 4 to 11 (mean=7.4; SD=2.1)",98.15242494226328
691,PRECIS-2,"Statistically significant differences favour the CLP arm, but these are small, and not statistically significant.",fulltext," statistically significant differences between arms in EQ-5D or SF-36 (SF-6D) health state values. Observed differences in QALYs favour the CLP arm, but these are small, and not statistically significant",99.11504424778761
691,PRECIS-2,"Recruitment was 39 from the South West, 75 from the Poole centre and 50 from the Poole centre.",fulltext," Recruitment was 39 from the Bristol centre, 75 from the Southampton/Portsmouth Centre and 50 from the Poole centre",91.48936170212765
692,PRECIS-2,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",fulltext,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",100.0
692,PRECIS-2,"Mobility, fatigue, and the impact of the disease on the patient's life were measured.",fulltext,"Mobility, fatigue, and the impact of the disease on the patient's life were measured.",100.0
692,PRECIS-2,"Thirty-five adults (N = 28 Females) were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",fulltext," were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",79.41176470588236
692,PRECIS-2,"Two measurement times are carried out in pre-post intervention, at baseline and after eight weeks.",fulltext,"Two measurement times are carried out in pre-post intervention, at baseline and after eight weeks.",100.0
692,PRECIS-2,All measurements were carried out at two phases of the study (eight weeks after randomization).,fulltext,All measurements were carried out at two phases of the study T1 (baseline) and T2 (eight weeks after randomization).,100.0
692,PRECIS-2,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors and aged between 18 and 65 (4) able to give informed consent and to understand French.",fulltext,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",98.86363636363636
692,PRECIS-2,"Participants were persevering in Physical Activity. Only, three of them dropped out the PA program before the end.",fulltext,"ic. Patients were persevering in Physical Activity. Only, three of them dropped out the PA program before the end.",95.6140350877193
692,PRECIS-2,"The aim of this study was to assess the efficacy of a PA program compared to two types of psychological interventions – Mindfulness and Implementation Intention – delivered via internet, in reducing consequences of MS. Effects of practicing were unrelated to degree of impairment (i.e., EDSS level).",fulltext,"The aim of this study was to assess the efficacy of a PA program compared to two types of psychological interventions – Mindfulness and Implementation Intention – delivered via internet, in reducing consequences of MS. Effects of practicing were unrelated to degree of impairment (i.e., EDSS level).",100.0
692,PRECIS-2,Participants were asked to describe the sensations and to evoke any situation that made the exercise easier or even harder to perform.,fulltext, were asked to describe the sensations and to evoke any event or situation that made the exercise easier or even harder to perform.,91.04477611940298
692,PRECIS-2,"The procedures for this study were approved by research ethics committees (CPP) «Ile de France XI » (ID: 2016-A00537-44), authorized from The National Agency for the Safety of Medicines and Health (ANSM) and registered under the identification number ID: NCT03785483.",fulltext,"The procedures for this study were approved by research ethics committees (CPP) «Ile de France XI » (ID: 2016-A00537-44), authorized from The National Agency for the Safety of Medicines and Health (ASNM) and registered under the identification number ID: NCT03785483.",99.625468164794
692,PRECIS-2,"The Mindfulness condition group received daily training in the form of pre-recorded sessions (6 sessions of 10 minutes each equal to 1 h/day) using TailorBuilder application, aiming at developing awareness of emotions and sensations.",fulltext," Mindfulness-Based Intervention group (MBI) (n = 12) received daily Mindfulness training in the form of prerecorded sessions (6 sessions of 10 minutes each equal to one hour/day) using TailorBuilder (TB) application, aiming at developing awareness of emotions and sensations.",96.56652360515021
693,PRECIS-2,"Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective study.",fulltext,"usion. Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective",97.08333333333333
693,PRECIS-2,The same psychologist evaluated executive functions and selective attention before and after the training. For executive function the Mazes subtest of Executive module from the Neuropsychological Assessment battery (NAB) [17] and Tower of London Test (TOL) [18] were used. In the Mazes subtest we measured and evaluated the time for the completion of maze tasks with increasing difficulties.,fulltext,ctions the same psychologist evaluated executive functions and selective attention before and after the training. For executive function the Mazes subtest of Executive module from the Neuropsychological assessment battery (NAB) [17] and Tower of London Test (TOL) [18] were used. In the Mazes subtest we measured and evaluated the time for the completion of maze tasks with increasing diffic,98.20971867007673
693,PRECIS-2,"Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Ljubljana. We used the following assessment tools and procedures:",fulltext,"ssment Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Ljubljana. We used the following assessment tools and proc",96.37305699481865
693,PRECIS-2,"Data were analyzed by SPSS program for Windows®, version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program. Statistical significance was set at p ≤ 0.05.",fulltext,"alysis Data were analyzed by SPSS program for Windows ® , version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program. Statistical significance was set at p ",96.51741293532339
693,PRECIS-2,"Objectives: Spasticity, cognitive impairment, depression and fatigue significantly reduce the quality of life in multiple sclerosis (MS) patients. To find out whether nonpharmalogical treatment approaches can reduce these symptoms we investigated effects of sports climbing (SC) and yoga on spasticity, cognitive impairment, mood change and fatigue in MS patients.",fulltext,"Objectives: Spasticity, cognitive impairment, depression and fatigue significantly reduce the quality of life in multiple sclerosis (MS) patients. To find out whether nonpharmalogical treatment approaches can reduce these symptoms we investigated effects of sports climbing (SC) and yoga on spasticity, cognitive impairment, mood change and fatigue in MS patients.",100.0
693,PRECIS-2,Both programs were held once a week for 10 weeks. Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,fulltext,Both programs were held once a week for 10 weeks. Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,100.0
693,PRECIS-2,The study was approved by the National Medical Ethics Committee. Participants gave their written consent prior to the inclusion.,fulltext,ipants The study was approved by the National Medical Ethics Committee. Participants gave their written consent prior to the inc,94.53125
694,PRECIS-2,"MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS)9 score between 4 and 6.5 were eligible for inclusion. Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",fulltext,"MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) 9 score between 4 and 6.5 were eligible for inclusion. Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",100.0
694,PRECIS-2,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment). Physiotherapists who assessed the endpoints in a separate room were blinded and explicitly trained not to question patients or hippotherapists.",fulltext,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment). Physiotherapists who assessed the endpoints in a separate room were blinded and explicitly trained not to question patients or hippotherapists.",100.0
694,PRECIS-2,"Analyses were based on the modified intention-to-treat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment. The primary endpoint change of BBS from baseline to 12 weeks was calculated using an analysis of covariance (ANCOVA) with the fixed effects group, center, age, gender, EDSS classification, and baseline BBS (type 2 sums of squares). Missing values were imputed through the last observation carried forward (LOCF) value.",fulltext," Analyses were based on the modified intention-totreat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment. The primary endpoint change of BBS from baseline to 12 weeks was calculated using an analysis of covariance (ANCOVA) with the fixed effects group, center, age, gender, EDSS classification, and baseline BBS (type 2 sums of squares). Missing values were imputed through the last observation carried forward (LOCF) value",99.57446808510639
694,PRECIS-2,"MS-HIPPO was a prospective, randomized, examiner-blinded, multicenter, comparative trial with an allocation of 1:1 to the two groups: hippotherapy plus standard care compared to standard care alone (as prior to the study). The intervention lasted for 12 weeks.",fulltext,"MS-HIPPO was a prospective, randomized, examiner-blinded, multicenter, comparative trial with an allocation of 1:1 to the two groups: hippotherapy plus standard care compared to standard care alone (as prior to the study). The intervention lasted for 12 weeks.",100.0
694,PRECIS-2,"Primary endpoint was the change in the BBS (Berg Balance Scale) (0–13 (difference from BBS baseline to week 12). Secondary endpoints were changes from baseline in fatigue (Fatigue Severity Scale (FSS)),14,15 health-related quality of life (Multiple Sclerosis Quality of Life-54 (MSQoL-54)),16 pain (Visual Analogue Scale (VAS)),17,18 and spasticity (Numeric Rating Scale (NRS)).",fulltext,"primary endpoint was the change in the BBS 10–13 (difference from BBS baseline to week 12). Secondary endpoints were changes from baseline in fatigue (Fatigue Severity Scale (FSS)), 14,15 health-related quality of life (Multiple Sclerosis Quality of Life-54 (MSQoL-54)), 16 pain (Visual Analogue Scale (VAS)), 17,18 and spasticity (Numeric Rating Scale (NRS)).",94.17989417989419
694,PRECIS-2,"Hippotherapy as a complementary treatment can be defined as one-patient-one-horse physiotherapy treatment with influence on muscle tone (reduction in spasticity) and breathing, strengthening the torso muscles, improving balance control and coordination, as well as gait. In addition, hippotherapy promotes social communication in the patients' lives and strengthens their self-esteem.",fulltext,"Hippotherapy as a complementary treatment can be defined as one-patient-one-horse physiotherapy treatment with and on the horse. The primary goals of hippotherapy are regulating muscle tone (reduction in spasticity) and breathing, strengthening the torso muscles, improving balance control and coordination, as well as gait. In addition, hippotherapy promotes social communication in the patients’ lives and strengthens their self-esteem.",98.4375
694,PRECIS-2,"Hippotherapy plus standard care, while below the threshold of a minimal clinically important difference, significantly improved balance and also fatigue, spasticity, and quality of life in MS patients.",fulltext,"Hippotherapy plus standard care, while below the threshold of a minimal clinically important difference, significantly improved balance and also fatigue, spasticity, and quality of life in MS patients.",100.0
695,PRECIS-2,"Participants whose clinical features appeared incompatible with a recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",fulltext,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",99.609375
695,PRECIS-2,Setting: Participants' homes in the City of Nottingham.,fulltext,Setting: Participants' homes in the City of Nottingham.,100.0
695,PRECIS-2,"An action plan was then proposed, and relevant phone numbers supplied. Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, after which EG patients had no subsequent contact with the OT",fulltext,"An action plan was then proposed, and relevant phone numbers supplied. Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, after which EG patients had no subsequent contact with the OT",100.0
695,PRECIS-2,Lost to follow-up: 2 Died: 3,fulltext,Lost to follow-up: Died: 3,92.85714285714286
695,PRECIS-2,"Baseline information from individuals in the EG was presented to an expert panel, which consisted of the research occupational therapist (OT) who carried out the subsequent education visit, a consultant in neurology and rehabilitation medicine, a GP, a social worker, a speech and language therapist, a physiotherapist and a nurse.",fulltext,"Baseline information from individuals in the EG was presented to an expert panel, which consisted of the research occupational therapist (OT) who carried out the subsequent education visit, a consultant in neurology and rehabilitation medicine, a GP, a social worker, a speech and language ",87.61329305135952
695,PRECIS-2,"Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information based on the expert panel discussion, a tailored version of the standard information package, and a specially constructed leaflet offering information about the participant's condition and about self-help organizations.",fulltext,"Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information based on the expert panel discussion, a tailored version of the standard information package, and a specially constructed leaflet offering information about the participant's condition and about self-help organizations.",100.0
695,PRECIS-2,Lost to follow-up: 3 Died: 1,fulltext,Lost to follow-up: Died: 3,89.28571428571429
695,PRECIS-2,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",fulltext,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",100.0
695,PRECIS-2,For binary outcomes univariate and multivariate logistic regression were performed. Analyses were performed both with and without adjustment for baseline rates of events in the groups.,fulltext,For binary outcomes univariate and multivariate logistic regression were performed. Analyses were performed both with and without adjustment for baseline rates of events in the groups.,100.0
695,PRECIS-2,"Primary outcome measures were reports of one or more falls or skin sores. At interview, participants were asked 'In the past 12 months, have you fallen? Have you had a skin sore?' Participants were assessed at baseline and 12 months later.",fulltext,"Primary outcome measures were reports of one or more falls or skin sores. At interview, participants were asked 'In the past 12 months, have you fallen? Have you had a skin sore?' Participants were assessed at baseline and 12 months later.",100.0
695,PRECIS-2,From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282 000). Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses:,fulltext,From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000). Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses:,99.56709956709958
696,PRECIS-2,The primary objective of this study was to compare two modes of natalizumab cessation interventions: immediate discontinuation group (IDG) versus a 12-month single infusion of serial MRI and number of relapses during a 12-month period in patients treated with natalizumab for at least 24 months.,fulltext,The primary objective of this study was to compare two modes of natalizumab cessation interventions: immediate discontinuation group (IDG) versus a TG approach as measured by serial MRI and number of relapses during a 12-month period in patients treated with natalizumab for at least 24 months.,93.55932203389831
696,PRECIS-2,"A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as well as during unscheduled visits due to relapses (within 3–5 days of any new symptom development). The Treating Neurologist evaluated the patient during the visits (scheduled and nonscheduled/urgent visits). An Examining Neurologist performed the Kurtzke EDSS blinded to the arm the patient was randomised to. Vitals, safety information and concomitant medications were obtained at the q3-month scheduled visits. See online supplementary appendix for an overview of assessments per time period.",fulltext,"A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as well as during unscheduled visits due to relapses (within 3–5 days of any new symptom development). The Treating Neurologist evaluated the patient during the visits (scheduled and nonscheduled/urgent visits). An Examining Neurologist performed the Kurtzke EDSS blinded to the arm the patient was randomised to. Vitals, safety information and concomitant medications were obtained at the q3-month scheduled visits. See online supplementary appendix for an overview of assessments per time period.",100.0
696,PRECIS-2,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study. Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,1,2 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.30 Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).",fulltext,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study. Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria, 19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0. 20 Candidates were excluded from the study if active disease was identified at baseline per clinical ( presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).",99.51456310679612
696,PRECIS-2,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.",fulltext,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.",100.0
696,PRECIS-2,The classification of hyperintense T2 and hypointense T1-lesion evolution on serial MRIs scans into categories such as new/enlarging was obtained. All number and activity analysis were performed using scan-to-scan comparisons without a priori identification of lesions. A new Gd-enhancing lesion was defined as a typical area of hyperintense signal on postcontrast T1-WI. A new or newly enlarging lesion on T2-WI and T1-WI at follow-up was defined as a round or oval lesion arising from an area previously considered normal appearing brain tissue and/or showing an identifiable increase in size from a previously stable-appearing lesion. T2 and T1-WI lesion activity was also evaluated as the number of new and enlarging lesions on T2-WI and T1-WI at follow-up was defined as a round or oval lesion arising from an area previously considered normal appearing brain tissue and/or showing an identifiable increase in size from a previously stable-appearing lesion.,fulltext,"The classification of hyperintense T2 and hypointense T1-lesion evolution on serial MRI scans into categories such as new/enlarging was obtained. All number and activity analysis were performed at time points 0, 6 and 12 months after last natalizumab infusion. A new Gd-enhancing lesion was defined as a typical area of hyperintense signal on postcontrast T1-WI. A new or newly enlarging lesion on T2-WI and T1-WI at follow-up was defined as a round or oval lesion arising from an area previously considered normal appearing brain tissue and/or showing an identifiable increase in size from a previously stable-appearing lesion. T2 and 2 W",62.57796257796257
696,PRECIS-2,"Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA",fulltext,"Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA",100.0
696,PRECIS-2,"Patients in both groups may have received additional optional treatment with intravenous myethylprednisolone (IVMP) in the first 6 months post-natalizumab discontinuation. The dose of IVMP treatment was at the discretion of the treating physician in agreement with the patient and included (A) no IVMP treatment, (B) 1 g/day q4 weeks during 6 months after last natalizumab infusion.",fulltext,"Patients in both groups may have received additional optional treatment with intravenous myethylprednisolone (IVMP) in the first 6 months post-natalizumab discontinuation. The dose of IVMP treatment was at the discretion of the treating physician in agreement with the patient and included (A) no IVMP treatment, (B) 1 g/day q4 weeks during 6 months after last natalizumab infusion ",100.0
697,PRECIS-2,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,fulltext,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,100.0
697,PRECIS-2,"The group program was conducted at a local community center for six participants and a physiotherapist allocated intervention (n = 26 center, n = 24 home), 47 completed post-assessment and 44 follow-up assessment.",fulltext," Community center-based and home-based exercise program. Participants: Fifty people with MS were randomized and completed allocated intervention (n = 26 center, n = 24 home), 47 completed post-assessment and 44 follow-up assessment.",74.64788732394366
697,PRECIS-2,"Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to an individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.",fulltext,"Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to suit individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.",99.1701244813278
697,PRECIS-2,"Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia. Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other neurological or orthopedic condition that would affect their function.",fulltext,"Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia. Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other ",82.36775818639799
697,PRECIS-2,"Participants in both groups were encouraged to work at a pace at which they could rest if they felt fatigue, or had a perceived exertion of greater than 7/10 on the modified Borg scale.",fulltext,"Participants were encouraged to work at a pace at which they could exercise for the full 6 minutes, but could rest if they felt fatigue, or had a perceived exertion of greater than 7/10 on the modified Borg scale.",91.89189189189189
697,PRECIS-2,"The exercise program for both groups included two, 60-minute sessions per week, held at least 2 days apart for 8 weeks. Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",fulltext,"The exercise program for both groups included two, 60-minute sessions per week, held at least 2 days apart for 8 weeks. Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",100.0
697,PRECIS-2,Fifty people with MS were randomized and completed baseline assessment; 47 completed post-assessment and 44 follow-up assessment.,fulltext,"Fifty people with MS were randomized and completed allocated intervention (n = 26 center, n = 24 home), 47 completed post-assessment and 44 follow-up assessment.",92.24806201550388
697,PRECIS-2,Data were analyzed according to the intention-to-treat principle. Differences between groups at baseline were analyzed using analysis of variance (ANOVA) for continuous data and Mann-Whitney U tests for interval data. Differences in outcome measures between the baseline and pre-assessments were compared using paired samples t-tests.,fulltext, Data were analyzed according to the intention-totreat principle. Differences between groups at baseline were analyzed using analysis of variance (ANOVA) for continuous data and Mann-Whitney U tests for interval data. Differences in outcome measures between the baseline and pre-assessments were compared using paired samples t-tests,99.40119760479041
697,PRECIS-2,The primary outcome was gait speed (10-meter walk test). Secondary outcomes were gait endurance (6-minute walk test) and balance (Berg Balance Scale).,fulltext,The primary outcome was gait speed (10-meter walk test). Secondary outcomes were gait endurance (6-minute walk test) and balance (Berg Balance Scale).,100.0
705,PRECIS-2,"We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach. We examined differences between groups in mean weight loss at 12 wk using a linear mixed-effects model, including all randomized participants per group assignment (i.e., including those with missing follow-up data and regardless of compliance with the intervention) and adjusted for age and site.",fulltext,"We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach. We examined differences between groups in mean weight loss at 12 wk using a linear mixedeffects model, including all randomized participants per group assignment (i.e., including those with missing followup data and regardless of compliance with the intervention) and adjusted for age and site.",99.53596287703016
705,PRECIS-2,"Twice throughout the program, participants completed the validated Step Test and Exercise Prescription to receive a personalized target heart rate to strive for during aerobic activities (22).",fulltext,"Twice throughout the program, participants completed the validated Step Test and Exercise Prescription to receive a personalized target heart rate to strive for during aerobic activities (22).",100.0
705,PRECIS-2,Measurement sessions were held at baseline and 12 wk (intervention group only) and 12 months (both groups).,fulltext,Measurement at baseline and 12 wk (both groups) and 12 months (intervention group only) in,63.55140186915889
705,PRECIS-2,"The full study protocol has been published elsewhere (14). Briefly, we conducted a pilot, pragmatic randomized controlled trial (pRCT; parallel groups, stratified by site) in Ontario, Canada.",fulltext,"The full study protocol has been published elsewhere (14). Briefly, we conducted a pilot, pragmatic randomized controlled trial (pRCT; parallel groups, stratified by site) in Ontario, Canada.",100.0
705,PRECIS-2,Eighty male fans of two ice hockey teams from the Ontario Hockey League (the London Knights and the Sarnia Sting) were randomized to either intervention (Hockey FIT) or comparator (wait-list control).,fulltext,Eighty male fans of two ice hockey teams from the Ontario Hockey League (40 men from each of London and Sarnia) were recruited and randomized to either intervention (Hockey FIT) or comparator (wait-list control).,90.0
705,PRECIS-2,"Trial outcome measures including measurement protocols are described in detail elsewhere (14). In brief, the planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.",fulltext,"Trial outcome measures including measurement protocols are described in detail elsewhere (14). In brief, the planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.",100.0
705,PRECIS-2,"A sample size calculation for the definitive RCT was based on a 5% difference in weight between the intervention and comparator at 12 months (20). Assuming an SD of 19.9%, 80% power, a 0.05 two-sided significance level, and a conservative 25% loss to follow-up estimate, 335 men in each arm (670 total) would be required.",fulltext,"A sample size calculation for the definitive RCT was based on a 5% difference in weight loss between intervention and comparator at 12 months (20). Assuming an SD of 19.9%, 80% power, a 0.05 two-sided significance level, and a conservative 25% loss to follow-up estimate, 335 men in each arm (670 total) would be required.",98.75389408099689
705,PRECIS-2,"At 12 wk, we also found between-group differences favoring the intervention for BMI, waist circumference, systolic BP, steps per day, healthful eating, fatty food, and self-rated health. Although groups were similar in eligibility at sitting time, self-esteem, improvements were observed within the intervention group at 12 wk.",fulltext,"At 12 wk, we also found between-group differences favoring the intervention for BMI, waist circumference, systolic BP, steps per day, healthful eating, fatty food, and selfrated health. Although groups were similar in diastolic BP, sitting time, and self-esteem, improvements were observed within the intervention group at 12 wk.",96.63608562691131
705,PRECIS-2,"The 12-week active phase of the intervention included the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered via presentation and discussion, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",fulltext,"ed the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",82.92682926829268
705,PRECIS-2,"In the development of Hockey FIT, specific adaptations to FFIT included modifying program content to the North American context (e.g., language used in relation to education on healthy eating) and to hockey in particular (e.g., for the exercise component, off-ice hockey-related drills and conditioning exercises were incorporated). Components from HealthStepsTM that were integrated into Hockey FIT included the following: 1) lifestyle prescriptions for healthy eating, PA (i.e., steps) and exercise, and 2) eHealth technologies including the private and customizable online social network platform and the HealtheStepsTM smartphone app designed to help participants maintain their PA and exercise goals in the long term.",fulltext,"In the development of Hockey FIT, specific adaptations to FFIT included modifying program content to the North American context (e.g., language used in relation to education on healthy eating) and to hockey in particular (e.g., for the exercise component, off-ice hockey-related drills and conditioning exercises were incorporated). Components from HealtheSteps TM that were integrated into Hockey FIT included the following: 1) lifestyle prescriptions for healthy eating, PA (i.e., steps) and exercise, with the latter involving a simple fitness test that provided men with a target heart rate for exercise, and 2) eHealth technologies including the private and customizable online social network platform and the HealtheSteps TM smartphone app designed to help participants maintain their PA and exercise goals in the long term.",100.0
705,PRECIS-2,One individual withdrew after randomization because he was displeased with the comparator group assignment.,fulltext,One individual withdrew after randomization because he was displeased with allocation to the comparator group.,89.7196261682243
705,PRECIS-2,"Recruitment occurred using a variety of methods (e.g., hockey team email blasts and social media posts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena). Eligible participants were male 35–65 yr old with a BMI of ≥28 kg·m−2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",fulltext,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena). Eligible participants were male 35–65 yr old with a BMI of Q28 kgIm j2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",99.14163090128756
712,PRECIS-2,"Objective: to analyze the effects of acupressure on the sanyinjiao point for pregnant women in labor at public maternity wards. Method: single-blind controlled clinical trial, randomly done employing a pragmatic profile. We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.",fulltext,"Objective: to analyze the effects of acupressure on the sanyinjiao point for pregnant women in labor at public maternity wards. Method: single-blind controlled clinical trial, randomly done employing a pragmatic profile. We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.",100.0
712,PRECIS-2,"The intensity of the pain was evaluated using the Visual Analogue Scale (VAS). Results: The averages for the pain measured using the VAS were not different for the three groups that were a part of the study (p-value=0.0929), however they were less in the acupressure groups immediately after receiving the treatment (p-value=<0.0001).",fulltext,"The intensity of the pain was evaluated using the Visual Analogue Scale (VAS). Results: The averages for the pain measured using the VAS were not different for the three groups that were a part of the study (p-value=0.0929), however they were less in the acupressure groups immediately after receiving the treatment (p-value=<0.0001).",100.0
712,PRECIS-2,"The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",fulltext,"The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",100.0
712,PRECIS-2,"The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups: acupressure (SP6), touch group (TG)/placebo and the control group (CG).",fulltext,"The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups: acupressure (SP6), touch group (TG)/placebo and the control ",95.80152671755725
712,PRECIS-2,Figure 2 - Procedures for the collection of data,fulltext,Figure 2 - Procedures for the collection of data,100.0
712,PRECIS-2,"We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes. The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",fulltext,"We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes. The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",100.0
712,PRECIS-2,The acupressure was applied on the sanyinjiao point during the contractions for 20 minutes. Then the intensity of the pain was evaluated using the Visual Analogue Scale (VAS).,fulltext,The acupressure was applied on the sanyinjiao point during the contractions for 20 minutes. Then the intensity of the pain was evaluated using the Visual Analogue Scale (VAS).,100.0
712,PRECIS-2,The researcher that was responsible for applying the acupressure went through 32 hours' worth of training. A child-cushioned electronic anthropometric scale was used to control and to put consistent pressure on the thumps until the researcher could apply such pressure for the SP6 and TG groups.,fulltext,The researcher that was responsible for applying the acupressure went through 32 hours' worth of training. A child-cushioned electronic anthropometric scale was used to control and to put consistent pressure on the thumps until the researcher could apply such pressure for the SP6 and TG groups.,100.0
713,PRECIS-2,"Self-reported exacerbations were measured by the question: 'How often during the previous 6 months have you had a serious exacerbation of the lungs?' Satisfaction with participation in the research was measured at month 12 by a nine-item five-point Likert-scale question: 'To what degree do you agree or disagree with the following statements about participation in the research?' The items were: useful, important, worth the time, constructive, informative, organized, easy, entertaining and demanding.",fulltext,"Self-reported exacerbations were measured by the question: ‘How often during the previous 6 months have you had a serious exacerbation of the lungs?’ Satisfaction with participation in the research was measured at month 12 by a nine-item five-point Likert-scale question: ‘To what degree do you agree or disagree with the following statements about participation in the research?’ The items were: useful, important, worth the time, constructive, informative, organized, easy, entertaining and demanding.",100.0
713,PRECIS-2,"Data collection was carried out by research nurses. An invitation letter signed by the patient's physician was sent to potential participants explaining that the study was a clinical, family trial and that as a client of the physician, the person had been identified as a possible participant and that in addition, participation by a close family member was requested.",fulltext,"Data collection was carried out by research nurses. An invitation letter signed by the patient's physician was sent to potential participants explaining that the study was a clinical, family trial and that as a client of the physician, the person had been identified as a possible participant and that in addition, participation by a close family member was requested.",100.0
713,PRECIS-2,The intervention was an addition to traditional health care which the control group received.,fulltext,The intervention was an addition to traditional health care which the control group received.,100.0
713,PRECIS-2,"At the first appointment, after signing an informed consent, the first data collection took place. Participants input information privately into an electronic database and the research staff conducted clinical measurements. Data were collected at baseline and at month 12.",fulltext,"At the first appointment, after signing an informed consent, the first data collection took place. Participants input information privately into an electronic database and the research staff conducted clinical measurements. Data were collected at baseline and at month 12.",100.0
713,PRECIS-2,Intention-to-treat analysis was not carried out.,fulltext,Intention-to-treat analysis was not carried out.,100.0
713,PRECIS-2,It was adjusted to the particular needs of the patients and families to find out what is meaningful for them in life as regards health and jointly decide on that which is possible and relevant for each patient and family.,fulltext,th patients and families to find out what is meaningful for them in life as regards health and jointly decide on that which is possible and relevant for each patient and family.,80.09049773755656
713,PRECIS-2,All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,fulltext,All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,100.0
713,PRECIS-2,No criteria were set for family members accompanying the patients.,fulltext,No criteria were set for family members accompanying the patients.,100.0
713,PRECIS-2,was the basis for this intervention. It was adjusted to the particular needs of young people with COPD in its early stages.,fulltext,was the basis for this intervention. It was adjusted to the particular needs of young people with COPD in its early stages.,100.0
713,PRECIS-2,"The following data were collected: Demographic data, smoking status (point prevalence abstinence) measured in exhaled breathing by a carbon monoxide monitor (piCO+Smokerlyzer®) where the cut-off point for abstinence was considered ≤6",fulltext,"The following data were collected: Demographic data, smoking status (point prevalence abstinence) measured in exhaled breathing by a carbon monoxide monitor (piCO + Smokerlyzer â ) where the cut-off point for abstinence was considered ≤6",100.0
713,PRECIS-2,Enrolment ended when patients' registry in all possible clinical sites had been scanned. Data collection lasted from June 2009–March 2013.,fulltext,Enrolment ended when patients' registry in all possible clinical sites had been scanned. Data collection lasted from June 2009–March 2013.,100.0
713,PRECIS-2,The treatment site was a clinical research centre located on a university-hospital campus.,fulltext,The treatment site was a clinical research centre located on a university-hospital campus.,100.0
713,PRECIS-2,"Patients, 45-65 years old, with mild and moderate chronic obstructive pulmonary disease were invited with a family member.",fulltext,"Patients, 45-65 years old, with mild and moderate chronic obstructive pulmonary disease were invited with a family member.",100.0
714,PRECIS-2,Setting Four general practices in England.,fulltext,Setting Four general practices in England.,100.0
714,PRECIS-2,Telephone consultations are safe alternatives in the triage of requests for same day appointments.,fulltext,Telephone consultations are safe alternatives in the triage of requests for same day appointments.,100.0
714,PRECIS-2,We used the χ2 test or Fisher's exact test (for small numbers) to analyse categorical data.,fulltext,We used the ˜ 2 test or Fisher’s exact text (for small numbers) to analyse categorical data.,97.8021978021978
714,PRECIS-2,"Recruitment—From a total of 56 062 patients we identified 3860 adults on the practice's asthma registers, of whom 1813 had requested a bronchodilator in the previous six months.",fulltext,"Recruitment— From a total of 56 062 patients we identified 3860 adults on the practices’ asthma registers, of whom 1813 had requested a bronchodilator in the previous six months.",99.43502824858757
714,PRECIS-2,"To allow for an anticipated 25% of subjects failing to complete questionnaires, we estimated that we needed to recruit 225 patients.",fulltext,"To allow for an anticipated 25% of subjects failing to complete questionnaires, we estimated that we needed to recruit 225 patients.",100.0
714,PRECIS-2,Consultation record (n=140),fulltext,Consultation record (n=140),100.0
714,PRECIS-2,"Recruitment—From a total of 56 062 patients we identified 3860 adults on the practice's asthma registers, of whom 1813 had requested a bronchodilator in the previous six months. Of the 1920 eligible patients (69%) who were due for an annual review, 307 were excluded (half because they had chronic obstructive pulmonary disease).",fulltext,"Recruitment— From a total of 56 062 patients we identified 3860 adults on the practices’ asthma registers, of whom 1813 had requested a bronchodilator in the previous six months. Of the 1239 patients (69%) who were due for an annual review, 307 were excluded (half because they had chronic obstructive pulmonary disease).",96.35258358662614
714,PRECIS-2,"Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient's clinical need. Details about the consultation, including failed attempts at phone calls and the duration of the consultation, were recorded immediately after the review on a piloted consultation record.",fulltext,"nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient’s clinical need. Details about the consultation, including failed attempts at phone calls and the duration of the consultation, were recorded immediately after the review on a piloted consultation record.",100.0
714,PRECIS-2,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient's clinical need.,fulltext,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient's clinical need.,100.0
714,PRECIS-2,"Outcome measures—Primary outcome measures were the proportion of patients reviewed within three months of randomisation and change in asthma related quality of life, as measured by the Juniper mini asthma quality of life questionnaire, over the three months after the intervention.",fulltext,"Outcome measures — Primary outcome measures were the proportion of patients reviewed within three months of randomisation and change in asthma related quality of life, as measured by the Juniper mini asthma quality of life questionnaire. 14 This validated instrument",89.6797153024911
714,PRECIS-2,Participants 278 adults who had not been reviewed in the previous 11 months.,fulltext,Participants 278 adults who had not been reviewed in the previous 11 months.,100.0
714,PRECIS-2,To measure asthma morbidity we used the ,fulltext,To measure asthma morbidity we used the ,100.0
714,PRECIS-2,Data from records (n=135),fulltext,Data from records (n=135),100.0
714,PRECIS-2,"Guidelines on the management of asthma emphasise the importance of regular review, and systematic recall",fulltext,"Guidelines on the management of asthma emphasise the importance of regular review, and systematic recall",100.0
714,PRECIS-2,Data from records (n=134),fulltext,Data from records (n=134),100.0
714,PRECIS-2, a validated score incorporating three questions recommended by the Royal College of Physicians as outcome indicators for routine use in asthma care.,fulltext, a validated score incorporating three questions recommended by the Royal College of Physicians as outcome indicators for routine use in asthma care.,100.0
715,PRECIS-2,Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.,fulltext,Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.,100.0
715,PRECIS-2,The former was based on evaluation of all participants who completed the five treatment sessions and focused on a complete case analysis; the latter was based on evaluation of all trial participants as allocated.,fulltext,The former was based on evaluation of all participants who completed the five treatment sessions and focussed on a complete case analysis; the latter was based on evaluation of all trial participants as allocated.,100.0
715,PRECIS-2,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,fulltext,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,100.0
715,PRECIS-2,"After gaining patient consent, demographics and disease activity scores in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",fulltext,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",99.581589958159
715,PRECIS-2,"This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor.",fulltext,"This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor.",100.0
715,PRECIS-2,"The primary outcome was the disease activity score (DAS28) assessed at baseline, weeks 13, 26, 39 and 52; the non-inferiority margin being DAS28 change of 0.6.",fulltext,"The primary outcome was the disease activity score (DAS28) assessed at baseline, weeks 13, 26, 39 and 52; the non-inferiority margin being DAS28 change of 0.6.",100.0
715,PRECIS-2,"Exclusions were: unstabilised concomitant disease, awaiting joint surgery and the inability to complete questionnaires unaided.",fulltext,"Exclusions were: unstabilised concomitant disease, awaiting surgery and ",56.69291338582677
715,PRECIS-2,"This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor. Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level. The CNS have experience in running nurse-led clinics and usually have a postgraduate qualification in rheumatology nursing and/or prescribing.",fulltext,"This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor. Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level. The CNS have experience in running nurse-led clinics and usually have a postgraduate qualification in rheumatology nursing and/ or prescribing.",100.0
715,PRECIS-2,The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria);,fulltext,The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria);,100.0
715,PRECIS-2,"When patients arrived at the clinic, the independent assessor performed 'joint counts' for DAS28 and then oversaw the completion of self-reported pain visual analogue scale (pain-VAS), fatigue VAS and duration of morning stiffness. The patients were then given questionnaires in 'freepost' return envelopes before consultation with their allocated practitioner.",fulltext,"When patients arrived at the clinic, the independent assessor performed ‘joint counts’ for DAS28 and then oversaw the completion of self-reported pain visual analogue scale (pain-VAS), fatigue-VAS and duration of morning stiffness. The patients were then given questionnaires in ‘freepost’ return envelopes before consultation with their allocated practitioner.",100.0
722,PRECIS-2,"All participants were also reviewed one month post-randomization and at intervening 3 month intervals, but these could be conducted by telephone.",fulltext,"All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone.",99.3103448275862
722,PRECIS-2,Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.,fulltext,Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.,100.0
722,PRECIS-2,"Participants comprised 50.6% Indigenous Australians and 60.8% had established CVD. At baseline, use of combination treatment was 50.1%.",fulltext,"Participants comprised 50.6% Indigenous Australians and 60.8% had established CVD. At baseline, use of combination treatment was 50.1%.",100.0
722,PRECIS-2,"Analyses of change in systolic BP and total cholesterol were conducted using longitudinal linear mixed models including all values collected during follow-up. Models included treatment, visit, treatment-by-visit interaction, and the baseline systolic BP or total cholesterol.",fulltext,"Analyses of change in systolic BP and total cholesterol were conducted using longitudinal linear mixed models including all values collected during follow-up. Models included treatment, visit, treatment-by-visit interaction, and the baseline systolic BP or total cholesterol.",100.0
722,PRECIS-2,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 BP lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",fulltext,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and 2 BP lowering therapies for 4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",100.0
722,PRECIS-2,A total of 623 participants were randomized from 33 centres (12 Aboriginal Medical Services) between January 2010 and May 2012 (Figure 1). Failure to recruit the planned number of participants reflected insufficient resources to continue enrolment.,fulltext,A total of 623 participants were randomized from 33 centres (12 Aboriginal Medical Services) between 922 European Journal of Preventive Cardiology 22(7) Downloaded from https://academic.oup.com/eurjpc/article/22/7/920/5927084 by Inactive user on 17 July 2023 January 2010 and May 2012 (Figure 1). Failure to recruit the planned number of participants reflected insufficient resources to continue enrolment.,100.0
722,PRECIS-2,"Participants were excluded if they were unable to provide informed consent, unlikely to complete study procedures, or had a contraindication to any component of at least one of two polypills – version 1 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, atenolol 50 mg) or version 2 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg).",fulltext," contraindications to any component of at least one of two polypills – version 1 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, atenolol 50 mg) or version 2 (containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg).",68.38046272493573
722,PRECIS-2,"All participants were also reviewed one month post-randomization and at intervening 3 month intervals, but these could be conducted by telephone. BP (measured with the Omron 7 0SCP II device) and fasting lipids (measured at local laboratories) were obtained at baseline, 12 months, 24 months and the final visit.",fulltext,"All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone. BP (measured with the Omron 705CP II device) and fasting lipids (measured at local laboratories) levels were obtained at baseline, 12 months, 24 months and the final visit.",99.03846153846155
722,PRECIS-2,"At one extreme, patients ineligible for any concessions were charged the standard co-payment (approximately AUD$35/month for each medication). At the other extreme, the polypill was dispensed without charge at Indigenous health services operating under the Section 100 scheme of the National Health Act.",fulltext,"At one extreme, patients ineligible for any concessions were charged the standard co-payment (approximately AUD$35/month for each medication). At the other extreme, the polypill was dispensed without charge at Indigenous health services operating under the Section 100 scheme of the National Health Act.",100.0
725,PRECIS-2,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population.12 The OSS provides a total score based on the patient's subjective assessment of pain and function. It contains 12 items, each with 5 categories of response, and a range of total scores of 0 (worst outcome) to 48 (best outcome).13 The OSS was collected by postal questionnaires at 6, 12, and 24 months.",fulltext,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population. 12 The OSS provides a total score based on the patient’s subjective assessment of pain and function. It contains 12 items, each with 5 categories of response, and a range of total scores of 0 (worst outcome) to 48 (best outcome). 13 The OSS was collected by postal questionnaires at 6, 12, and 24 months.",100.0
725,PRECIS-2,"Analyses followed a prespecified analysis plan endorsed by the data monitoring and ethics committee, and were performed using Stata version 12 (StataCorp). All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.",fulltext,"Analyses followed a prespecified analysis plan, endorsed by the data monitoring and ethics committee, and were performed using Stata version 12 (StataCorp). All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.",100.0
725,PRECIS-2,Fracture fixation or humeral head replacement were performed by surgeons experienced in these techniques. Nonsurgical treatment was sling immobilization.,fulltext,Fracture fixation or humeral head replacement were performed by surgeons experienced in these techniques. Nonsurgical treatment was sling immobilization.,100.0
725,PRECIS-2,"Of 1250 patients screened, 563 (45%) were eligible and 687 (55%) were ineligible (Figure 1). The most common reason for exclusion (>1 reason per patient possible) was that a patient had comorbidities that precluded surgery or anesthetic.",fulltext,"s Of 1250 patients screened, 563 (45%) were eligible and 687 (55%) were ineligible (Figure 1). The most common reason for exclusion (>1 reason per patient possible) was that a patient had ",78.48101265822784
725,PRECIS-2,Fracture fixation or humeral head replacement were performed by surgeons experienced in these techniques. Nonsurgical treatment was sling immobilization. Standardized outpatient and community-based rehabilitation was provided to both groups.,fulltext,Fracture fixation or humeral head replacement were performed by surgeons experienced in these techniques. Nonsurgical treatment was sling immobilization. Standardized outpatient and community-based rehabilitation was provided to both groups.,100.0
725,PRECIS-2,To evaluate the clinical effectiveness of surgical vs nonsurgical treatment for adults with displaced fractures of the proximal humerus involving the surgical neck.,fulltext,To evaluate the clinical effectiveness of surgical vs nonsurgical treatment for adults with displaced fractures of the proximal humerus involving the surgical neck.,100.0
725,PRECIS-2,"Patients were followed up at 6, 12, and 24 months. Sample size was based on a minimal clinically important difference of 5 points for the Oxford Shoulder Score.",fulltext," at 6, 12, and 24 months. Sample size was based on a minimal clinically important difference of 5 points for the Oxford Shoulder Score.",84.375
725,PRECIS-2,Standardized outpatient and community-based rehabilitation was provided to both groups.,fulltext,Standardized outpatient and community-based rehabilitation was provided to both groups.,100.0
725,PRECIS-2,"A pragmatic, multicenter, parallel-group, randomized clinical trial, the Proximal Fracture of the Humerus Evaluation by Randomization (PROFHER) trial, recruited 250 patients aged 16 years or older (mean age, 66 years [range, 24-92 years]; 192 [77%] were female; and 249 [99.6%] were white) who presented at the orthopedic departments of 32 acute UK National Health Service hospitals between September 2008 and April 2011 within 3 weeks after sustaining a displaced fracture of the proximal humerus involving the surgical neck.",fulltext,"A pragmatic, multicenter, parallel-group, randomized clinical trial, the Proximal Fracture of the Humerus Evaluation by Randomization (PROFHER) trial, recruited 250 patients aged 16 years or older (mean age, 66 years [range, 24-92 years]; 192 [77%] were female; and 249 [99.6%] were white) who presented at the orthopedic departments of 32 acute UK National Health Service hospitals between September 2008 and April 2011 within 3 weeks after sustaining a displaced fracture of the proximal humerus involving the surgical neck.",100.0
725,PRECIS-2,Patients were followed up for 2 years (up to April 2013) and 215 had complete follow-up data.,fulltext,Patients were followed up for 2 years (up to April 2013) and 215 had complete follow-up data.,100.0
733,PRECIS-2,"Participants in the FaME arm, compared with usual care, reported more MVPA at 12 months, adding around 15 minutes of MVPA per day.",fulltext,"Participants in the FaME arm, compared with usual care, reported more MVPA at 12 months, adding around 15 minutes of MVPA per day.",100.0
733,PRECIS-2,Patients were excluded if they: • had experienced ≥3 falls in the previous year; • had unstable clinical conditions; • would be unable to follow instructions about exercise safely; or • were receiving palliative care.,fulltext,Patients were excluded if they: • had experienced ≥3 falls in the previous year; • had unstable clinical conditions; • would be unable to follow instructions about exercise safely; or • were receiving palliative care.,100.0
733,PRECIS-2,Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise.,fulltext,Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP. Patients were eligible to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise.,100.0
733,PRECIS-2,Baseline characteristics were compared informally between treatment arms. Comparisons between treatment arms were made using random-effects regression models to allow for clustering between practices.,fulltext,Baseline characteristics were compared informally between treatment arms. Comparisons between treatment arms were made using random-effects regression models to allow for clustering between practices.,100.0
733,PRECIS-2,"The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week. Physical activity was assessed using validated questionnaires: Phone-FITT, the Physical Activity Scale for the Elderly (PASE), and the Community Healthy Activities Model Program for Seniors (CHAMPS). The primary outcome measure was the CHAMPS questionnaire.",fulltext,"The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week. Physical activity was assessed using three validated questionnaires: Phone-FITT, the Physical Activity Scale for the Elderly (PASE), and the Community Healthy Activities Model Program for Seniors (CHAMPS). The primary outcome measure was the CHAMPS questionnaire.",100.0
733,PRECIS-2,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",fulltext,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",100.0
733,PRECIS-2,"Participants were followed up at baseline, 6 months, and 12 months at their general practice or usual care venue.",fulltext,"Participants were followed up every 6 months after the end of the intervention period, until 24 months. The",59.29203539823009
733,PRECIS-2,"The trial took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",fulltext," took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",95.98214285714286
733,PRECIS-2,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people. Both interventions were delivered for 24 weeks. Participants in the usual-care arm were not offered either programme.",fulltext,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people. Both interventions were delivered for 24 weeks. Participants in the usual-care arm were not offered either programme.",100.0
733,PRECIS-2,"The proportions reporting at least 150 minutes of MVPA per week rose from 40% (136/342) to 49% (95/193) in the FaME arm, 41% (150/362) to 43% (99/185) in the OEP arm, and 37.5% (150/400) to 38% (84/222) in the usual-care arm; 12 months after the end of the intervention.",fulltext," 40% (136/342) to 49% (95/193) in the FaME arm, 41% (150/362) to 43% (79/185) in the OEP arm, and 37.5% (150/400) to 38% (84/222) in the usual-care arm 12 months after the end of the intervention.",72.22222222222221
733,PRECIS-2,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise.",fulltext,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP. Patients were eligible to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise.",100.0
733,PRECIS-2,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people.",fulltext,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people.",100.0
733,PRECIS-2,"Participants were analysed in the groups to which they were randomised, regardless of whether they received the intervention or not, and multiple imputation was used to include all participants in the analyses.",fulltext,"Participants were analysed in the groups to which they were randomised, regardless of whether they received the intervention or not, and multiple imputation was used to include all participants in the analyses.",100.0
733,PRECIS-2,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham.",fulltext,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham.",100.0
733,PRECIS-2,"The odds ratios for reaching the target of 150 minutes of MVPA per week in the FaME arm was 1.78 (95% confidence interval [CI] =1.11 to 2.87, P = 0.02). There was no statistically significant difference in reaching the target between the OEP and usual-care arms (OR 1.17 [95% CI = 0.72 to 1.92], P = 0.52).",fulltext,"The odds ratio (OR) for reaching or exceeding the target of 150 minutes of MVPA per weeks in the FaME arm was 1.78 (95% confidence interval [CI] =1.11 to 2.87, P = 0.02). There was no statistically significant difference in reaching the target between the OEP and usual-care arms (OR 1.17 (95% CI = 0.72 to 1.92), P = 0.52).",99.67320261437908
